Search
Dexamethasone Treatment Options in Canada
A collection of 294 research studies where Dexamethasone is the interventional treatment. These studies are located in the Canada . Dexamethasone is used for conditions such as Multiple Myeloma, Postoperative Pain and Lymphoma.
37 - 48 of 294
Show Filters
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
Filter by Age
Filter by Type
Gender
Male
Female
Both
Type of Study
Interventional
Observational
Clinical Trial Phase
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
Unknown
Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921)
Completed
The purpose of this study is to assess the efficacy and safety of the combination of pembrolizumab (MK-3475) and docetaxel in the treatment of men with metastatic castration-resistant prostate cancer (mCRPC) who have not received chemotherapy for mCRPC but have progressed on or are intolerant to Next Generation Hormonal Agent (NHA).
There are two primary study hypotheses.
Hypothesis 1: The combination of pembrolizumab plus docetaxel plus prednisone is superior to placebo plus docetaxel plus pr... Read More
The purpose of this study is to assess the efficacy and safety of the combination of pembrolizumab (MK-3475) and docetaxel in the treatment of men with metastatic castration-resistant prostate cancer (mCRPC) who have not received chemotherapy for mCRPC but have progressed on or are intolerant to Next Generation Hormonal Agent (NHA).
There are two primary study hypotheses.
Hypothesis 1: The combination of pembrolizumab plus docetaxel plus prednisone is superior to placebo plus docetaxel plus prednisone with respect to Overall Survival (OS).
Hypothesis 2: The combination of pembrolizumab plus docetaxel plus prednisone is superior to placebo plus docetaxel plus prednisone with respect to Radiographic Progression-free Survival (rPFS) per Prostate Cancer Working Group (PCWG)-modified Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST 1.1) as assessed by blinded independent central review. Read Less
Gender:
MALE
Ages:
18 years and above
Trial Updated:
07/08/2025
Locations: University of South Alabama, Mitchell Cancer Institute ( Site 0065), Mobile, Alabama +214 locations
University of South Alabama, Mitchell Cancer Institute ( Site 0065), Mobile, Alabama
St. Joseph Heritage Healthcare ( Site 0069), Fullerton, California
University of Southern California Norris Comprehensive Cancer Center ( Site 0061), Los Angeles, California
USC Norris Oncology Hematology Newport Beach ( Site 0093), Newport Beach, California
University of California San Francisco ( Site 0023), San Francisco, California
University of Colorado Cancer Center ( Site 0022), Aurora, Colorado
Yale Cancer Center ( Site 0038), New Haven, Connecticut
Moffitt Cancer Center ( Site 0080), Tampa, Florida
Georgia Cancer Center at Augusta University ( Site 0026), Augusta, Georgia
Mount Sinai Hospital Medical Center ( Site 0042), Chicago, Illinois
Methodist Hospital- Merriillville ( Site 0008), Merrillville, Indiana
Karmanos Cancer Institute ( Site 0077), Detroit, Michigan
Henry Ford Health System ( Site 0039), Detroit, Michigan
Cancer & Hematology Centers of Western Michigan ( Site 0013), Grand Rapids, Michigan
Washington University School of Medicine ( Site 0057), Saint Louis, Missouri
St. Vincent Frontier Cancer Center ( Site 0016), Billings, Montana
Nebraska Cancer Specialists ( Site 0034), Omaha, Nebraska
Comprehensive Cancer Centers of Nevada ( Site 0092), Las Vegas, Nevada
John Theurer Cancer Center at Hackensack University Medical Center ( Site 0004), Hackensack, New Jersey
Associated Medical Professionals of NY ( Site 0060), Syracuse, New York
Duke Cancer Center ( Site 0010), Durham, North Carolina
W. G. Bill Hefner VA Medical Center ( Site 0029), Salisbury, North Carolina
University Hospitals Cleveland Medical Center ( Site 0036), Cleveland, Ohio
Oregon Health Sciences University ( Site 0031), Portland, Oregon
Carolina Urologic Research Center ( Site 0070), Myrtle Beach, South Carolina
Inova Schar Cancer Institute ( Site 0006), Fairfax, Virginia
Virginia Cancer Institute ( Site 0052), Richmond, Virginia
Blue Ridge Cancer Care ( Site 0086), Roanoke, Virginia
Centro de Oncologia e Investigacion Buenos Aires COIBA ( Site 1013), Berazategui, Buenos Aires
Instituto de Investigaciones Clinicas ( Site 1000), Mar del Plata, Buenos Aires
Centro de Diagnostico Urologico ( Site 1008), Buenos Aires, Caba
Hospital Britanico de Buenos Aires ( Site 1006), Buenos Aires, Caba
Sanatorio Parque ( Site 1002), Rosario, Santa Fe
Instituto de Investigaciones Metabolicas [Buenos Aires, Argentina] ( Site 1011), Buenos Aires, Not set
Hospital Aleman ( Site 1004), Buenos Aires, Not set
Instituto Medico Alexander Fleming ( Site 1010), Buenos Aires, Not set
CEMAIC ( Site 1014), Cordoba, Not set
St George Hospital ( Site 0157), Kogarah, New South Wales
Macquarie University ( Site 0151), Macquarie University, New South Wales
Port Macquarie Base Hospital ( Site 0153), Port Macquarie, New South Wales
Calvary Mater Newcastle ( Site 0148), Waratah, New South Wales
Redcliffe Hospital ( Site 0161), Redcliffe, Queensland
John Flynn Hospital & Medical Centre ( Site 0164), Tugun, Queensland
Hollywood Private Hospital ( Site 0163), Nedlands, Western Australia
Ordensklinikum Linz GmbH Elisabethinen ( Site 0373), Linz, Oberosterreich
Medizinische Universitat Graz ( Site 0374), Graz, Steiermark
SCRI-CCCIT GesmbH ( Site 0371), Salzburg, Not set
Medizinische Universitaet Wien ( Site 0375), Wien, Not set
Hospital de Caridade de Ijui ( Site 1038), Ijui, Rio Grande Do Sul
Uniao Brasileira de Educacao e Assistencia Hospital Sao Lucas da Pucrs ( Site 1021), Porto Alegre, Rio Grande Do Sul
Centro de Novos Tratamentos Itajai - Clinica de Neoplasias Litoral ( Site 1035), Itajai, Santa Catarina
Hospital de Base de Sao Jose de Rio Preto ( Site 1022), Sao Jose do Rio Preto, Sao Paulo
A.C. Camargo Cancer Center ( Site 1026), Sao Paulo, Not set
Nova Scotia Health Authority QEII-HSC ( Site 0114), Halifax, Nova Scotia
Hamilton Health Sciences-Juravinski Cancer Centre ( Site 0116), Hamilton, Ontario
Grand River Hospital ( Site 0120), Kitchener, Ontario
Lakeridge Health ( Site 0117), Oshawa, Ontario
Sunnybrook Research Institute ( Site 0108), Toronto, Ontario
Princess Margaret Cancer Centre ( Site 0107), Toronto, Ontario
CIUSSS du Bas Saint Laurent - Hopital Regional de Rimouski ( Site 0102), Rimouski, Quebec
CIUSSS de l Estrie - CHUS - Centre Hosp. Univ. Sherbrooke ( Site 0105), Sherbrooke, Quebec
CHU de Quebec-Universite Laval-Hotel Dieu de Quebec ( Site 0103), Quebec, Not set
Centro Investigación del Cáncer James Lind ( Site 1041), Temuco, Araucania
Rey y Oreilly Limitada ( Site 1048), Temuco, Araucania
Fundacion Arturo Lopez Perez ( Site 1049), Santiago, Region M. De Santiago
Pontificia Universidad Catolica de Chile ( Site 1047), Santiago, Region M. De Santiago
Bradford Hill Centro de Investigaciones Clinicas ( Site 1044), Santiago, Region M. De Santiago
Centro de Investigaciones Clinicas Vina del Mar ( Site 1042), Vina del Mar, Valparaiso
Peking University First Hospital ( Site 1303), Beijing, Beijing
The Fifth Medical Center of PLA General Hospital ( Site 1307), Beijing, Beijing
Beijing Cancer Hospital ( Site 1305), Beijing, Beijing
The First Affiliated Hospital of Xiamen University ( Site 1319), Xiamen, Fujian
Sun Yat Sen Memorial Hospital ( Site 1323), Guangzhou, Guangdong
The First Affiliated Hospital of Guangzhou Medical University ( Site 1330), Guangzhou, Guangdong
Harbin Medical University Cancer Hospital ( Site 1326), Harbin, Heilongjiang
Henan Cancer Hospital ( Site 1321), Zhengzhou, Henan
Hubei Cancer Hospital ( Site 1329), Wuhan, Hubei
Hunan Cancer Hospital ( Site 1320), Changsha, Hunan
Nanjing Drum Tower Hospital ( Site 1312), Nanjing, Jiangsu
Fudan University Shanghai Cancer Center ( Site 1300), Shanghai, Shanghai
Zhongshan Hospital Fudan University ( Site 1301), Shanghai, Shanghai
The Second Affiliated Hospital of Zhejiang University School of Medicine ( Site 1309), Hangzhou, Zhejiang
Zhejiang Provincial People's Hospital ( Site 1310), Hangzhou, Zhejiang
Hospital Pablo Tobon Uribe ( Site 1066), Medellin, Antioquia
Biomelab S A S ( Site 1067), Barranquilla, Atlantico
Clinica de la Costa Ltda. ( Site 1073), Barranquilla, Atlantico
Sociedad de Oncología Y Hematología del Cesar S.A.S. ( Site 1068), Valledupar, Cesar
Oncomedica S.A. ( Site 1057), Monteria, Cordoba
Instituto Nacional de Cancerologia E.S.E ( Site 1061), Bogota, Distrito Capital De Bogota
Clinica Colsanitas S.A. Sede Clinica Universitaria Colombia ( Site 1062), Bogota, Distrito Capital De Bogota
Oncologos del Occidente S.A. ( Site 1072), Pereira, Risaralda
Centro Medico Imbanaco de Cali S.A ( Site 1064), Cali, Valle Del Cauca
Hemato Oncologos S.A. ( Site 1065), Cali, Valle Del Cauca
C.H. de Saint Quentin ( Site 0481), Saint Quentin, Aisne
Clinique Sainte Anne ( Site 0431), Strasbourg, Alsace
Centre Jean Perrin ( Site 0434), Clermont-Ferrand, Auvergne
Centre Leon Berard ( Site 0422), Lyon, Auvergne
Institut Paoli Calmettes. ( Site 0419), Marseille, Bouches-du-Rhone
CHU Jean Minjoz ( Site 0423), Besancon, Doubs
CHU de Brest -Site Hopital Morvan ( Site 0441), Brest, Finistere
Institut Bergonie ( Site 0421), Bordeaux, Gironde
Institut Claudius Regaud IUCT Oncopole ( Site 0418), Toulouse, Haute-Garonne
Hopital Foch ( Site 0428), Suresnes, Hauts-de-Seine
Institut De Cancerologie De L Ouest ( Site 0448), Saint Herblain, Loire-Atlantique
Centre Hospitalier Regional du Orleans ( Site 0430), Orleans, Loiret
Centre D Oncologie de Gentilly ( Site 0432), Nancy, Meurthe-et-Moselle
C.H.U. Lyon Sud ( Site 0436), Pierre Benite, Rhone
CHU Amiens Picardie Site Sud Amiens ( Site 0438), Amiens, Somme
Institut Gustave Roussy ( Site 0416), Villejuif, Val-de-Marne
Institut Sainte Catherine ( Site 0447), Avignon, Vaucluse
Institut Mutualiste Montsouris ( Site 0446), Paris, Not set
Universitaetsklinikum Freiburg - Medizinische Klinik ( Site 0304), Freiburg, Baden-Wurttemberg
Universitaetsklinikum in Mannheim ( Site 0314), Mannheim, Baden-Wurttemberg
Studienpraxis Urologie ( Site 0309), Nuertingen, Baden-Wurttemberg
Universitaetsklinik fuer Urologie ( Site 0307), Tuebingen, Baden-Wurttemberg
Klinikum Rechts der Isar ( Site 0300), Muenchen, Bayern
Universitaetsklinik der Paracelsus Medizinischen Privatuniversitaet ( Site 0318), Nuernberg, Bayern
Universitaetsklinikum Wuerzburg ( Site 0302), Wuerzburg, Bayern
Universitaetsklinikum Goettingen ( Site 0345), Goettingen, Niedersachsen
Uniklinik RWTH Aachen ( Site 0308), Aachen, Nordrhein-Westfalen
Universitaetsklinikum des Saarlandes ( Site 0348), Homburg, Saarland
Universitaetsklinikum Jena ( Site 0305), Jena, Thuringen
Charite Universitaetsmedizin Berlin ( Site 0301), Berlin, Not set
Cork University Hospital ( Site 0727), Cork, Not set
Tallaght University Hospital ( Site 0730), Dublin, Not set
Mid Western Cancer Centre ( Site 0728), Limerick, Not set
Soroka Medical Center ( Site 0548), Beer Sheva, Not set
Assaf Harofeh MC ( Site 0547), Beer Yaakov-Zerifin, Not set
Rambam Medical Center ( Site 0543), Haifa, Not set
Hadassah Ein Kerem Medical Center ( Site 0546), Jerusalem, Not set
Meir Medical Center ( Site 0544), Kfar Saba, Not set
Rabin Medical Center ( Site 0545), Petach-Tikwa, Not set
Chaim Sheba Medical Center ( Site 0541), Ramat Gan, Not set
Sourasky Medical Center ( Site 0542), Tel Aviv, Not set
Istituto Clinico Humanitas Research Hospital ( Site 0452), Rozzano, Milano
Azienda Ospedaliera Cannizzaro ( Site 0458), Catania, Not set
A.O. Universitaria di Modena ( Site 0454), Modena, Not set
Istituto Nazionale Tumori IRCCS Fondazione Pascale ( Site 0457), Napoli, Not set
Azienda Ospedaliera San Camillo Forlanini ( Site 0455), Roma, Not set
Azienda Ospedaliera Santa Maria Terni ( Site 0456), Terni, Not set
Presidio Ospedaliero Santa Chiara ( Site 0451), Trento, Not set
National Cancer Center Hospital East ( Site 0702), Kashiwa, Chiba
Toho University Sakura Medical Center ( Site 0703), Sakura, Chiba
National Hospital Organization Shikoku Cancer Center ( Site 0716), Matsuyama, Ehime
Kanazawa University Hospital ( Site 0701), Kanazawa, Ishikawa
Kitasato University Hospital ( Site 0705), Sagamihara, Kanagawa
Yokohama City University Medical Center ( Site 0706), Yokohama, Kanagawa
Nara Medical University Hospital ( Site 0715), Kashihara, Nara
Kindai University Hospital ( Site 0714), Osakasayama, Osaka
Osaka University Hospital ( Site 0713), Suita, Osaka
Saitama Medical University International Medical Center ( Site 0708), Hidaka, Saitama
Dokkyo Medical University Saitama Medical Center ( Site 0707), Koshigaya, Saitama
Hamamatsu University Hospital ( Site 0720), Hamamatsu, Shizuoka
Yamaguchi University Hospital ( Site 0717), Ube, Yamaguchi
Chiba Cancer Center ( Site 0704), Chiba, Not set
Kyushu University Hospital ( Site 0718), Fukuoka, Not set
University of Miyazaki Hospital ( Site 0721), Miyazaki, Not set
Nagasaki University Hospital ( Site 0719), Nagasaki, Not set
Toranomon Hospital ( Site 0711), Tokyo, Not set
Nippon Medical School Hospital ( Site 0709), Tokyo, Not set
Keio University Hospital ( Site 0710), Tokyo, Not set
National Cancer Center ( Site 0174), Goyang-si, Kyonggi-do
Seoul National University Bundang Hospital ( Site 0175), Seongnam-si, Kyonggi-do
Seoul National University Hospital ( Site 0171), Seoul, Not set
Asan Medical Center ( Site 0176), Seoul, Not set
Samsung Medical Center ( Site 0172), Seoul, Not set
Medisch Centrum Leeuwarden ( Site 0477), Leeuwarden, Fryslan
Ziekenhuis Gelderse Vallei ( Site 0485), Ede, Gelderland
Radboud University Medical Center ( Site 0470), Nijmegen, Gelderland
VieCuri Medisch Centrum ( Site 0487), Venlo, Limburg
Jeroen Bosch Ziekenhuis ( Site 1200), Den Bosch, Noord-Brabant
Catharina Ziekenhuis ( Site 0472), Eindhoven, Noord-Brabant
Antoni van Leeuwenhoek Ziekenhuis ( Site 0480), Amsterdam, Noord-Holland
Ziekenhuis Hilversum ( Site 0466), Hilversum, Noord-Holland
Ziekenhuisgroep Twente ( Site 0469), Hengelo, Overijssel
Reinier de Graaf Groep ( Site 0484), Delft, Zuid-Holland
Hagaziekenhuis ( Site 1201), Den Haag, Zuid-Holland
Chelyabinsk Regional Clinical Oncological Dispensary ( Site 0565), Chelyabinsk, Chelyabinskaya Oblast
Krasnoyarsk Regional Clinical Oncological Dispensary ( Site 0585), Krasnoyarsk, Krasnoyarskiy Kray
SBIH City clinical hospital named after D.D. Pletniov ( Site 0575), Moscow, Moskva
Russian Scientific Center of Radiology ( Site 0559), Moscow, Moskva
Central Clinical Hospital with Polyclinic ( Site 0562), Moscow, Moskva
National Medical Research Radiological Center ( Site 0556), Moscow, Moskva
Volga District Medical Center Federal Medical and Biological Agency ( Site 0572), Nizhny Novgorod, Nizhegorodskaya Oblast
Omsk Clinical Oncology Dispensary ( Site 0568), Omsk, Omskaya Oblast
SBHI Samara Regional Clinical Oncology Dispensary ( Site 0576), Samara, Samarskaya Oblast
Clinical Research Center of specialized types medical care-Oncology ( Site 0570), Saint Petersburg, Sankt-Peterburg
Russian Scientific Center of Radiology and Surgical Technologies ( Site 0567), Saint Petersburg, Sankt-Peterburg
SPb SBHI City Clinical Oncological Dispensary ( Site 0571), Saint Petersburg, Sankt-Peterburg
Leningrad Regional Oncology Center ( Site 0588), Saint-Petersburg, Sankt-Peterburg
Tomsk National Research Medical Center of Russian Academy of Sciences ( Site 0579), Tomsk, Tomskaya Oblast
Instituto Catalan de Oncologia - ICO ( Site 0330), L Hospitalet De Llobregat, Barcelona
Hospital Consorci Sanitari Parc Tauli ( Site 0335), Sabadell, Barcelona
Hospital Universitario Marques de Valdecilla ( Site 0336), Santander, Cantabria
Hospital Josep Trueta ( Site 0321), Girona, Gerona
Hospital del Mar ( Site 0333), Barcelona, Not set
Hospital Clinic ( Site 0323), Barcelona, Not set
Hospital Universitario Ramon y Cajal ( Site 0328), Madrid, Not set
Hospital Clinico San Carlos ( Site 0324), Madrid, Not set
Hospital Universitario HM Sanchinarro ( Site 0322), Madrid, Not set
Hospital Universitario Virgen de la Victoria ( Site 0337), Malaga, Not set
Hospital Virgen del Rocio ( Site 0329), Sevilla, Not set
National Cheng Kung University Hospital ( Site 0134), Tainen, Tainan
China Medical University Hospital ( Site 0132), Taichung, Not set
Taichung Veterans General Hospital ( Site 0133), Taichung, Not set
National Taiwan University Hospital ( Site 0131), Taipei, Not set
Taipei Veterans General Hospital ( Site 0135), Taipei, Not set
University Hospitals Bristol NHS Foundation Trust ( Site 0530), Bristol, Bristol, City Of
Cambridge University Hospitals NHS Trust ( Site 0540), Cambridge, Cambridgeshire
Torbay Hospital ( Site 0532), Torquay, Devon
Weston Park Hospital ( Site 0539), Sheffield, England
Royal Marsden Hospital ( Site 0526), Sutton, England
Mount Vernon Cancer Centre ( Site 0536), Northwood, Hertfordshire
Barts Cancer Institute ( Site 0483), London, London, City Of
University of North Midlands NHS Foundation Trust ( Site 0527), Stoke-on-Trent, Staffordshire
Conditions: Prostatic Neoplasms
A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma
Active Not Recruiting
This Phase Ib, multicenter, open-label study will evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of cevostamab monotherapy, cevostamab plus pomalidomide and dexamethasone (Pd) or cevostamab plus daratumumab and dexamethasone (Dd) which will be administered to participants with relapsed or refractory multiple myeloma (R/R MM) via intravenous (IV) infusion.
This Phase Ib, multicenter, open-label study will evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of cevostamab monotherapy, cevostamab plus pomalidomide and dexamethasone (Pd) or cevostamab plus daratumumab and dexamethasone (Dd) which will be administered to participants with relapsed or refractory multiple myeloma (R/R MM) via intravenous (IV) infusion. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/08/2025
Locations: City of Hope, Duarte, California +27 locations
City of Hope, Duarte, California
City of Hope - Lennar Foundation Cancer Center, Irvine, California
Colorado Blood Cancer Institute (CBCI) at Presbyterian/ St. Luke's Medical Center, Denver, Colorado
Karmanos Cancer Institute., Detroit, Michigan
Washington University School of Medicine, Saint Louis, Missouri
Peter MacCallum Cancer Centre, Melbourne, Victoria
The Alfred Hospital, Melbourne, Victoria
Cross Cancer Institute, Edmonton, Alberta
Hamilton Health Sciences, Hamilton, Ontario
University Health Network, Toronto, Ontario
Fakultni Nemocnice Ostrava, Ostrava, Not set
Rigshospitalet, København Ø, Not set
Hôpital Saint-Louis, Paris, Not set
CHU de Poitiers - La Miletrie, Poitiers, Not set
Rambam Medical Center, Haifa, Not set
Sourasky Medical Centre, Tel-Aviv, Not set
Asst Papa Giovanni Xxiii, Bergamo, Lombardia
A.O. Spedali Civili Di Brescia-P.O. Spedali Civili, Brescia, Lombardia
Yamagata University Hospital, Yamagata, Not set
Seoul National University Hospital, Seoul, Not set
Samsung Medical Center, Seoul, Not set
Uniwersyteckie Centrum Kliniczne, Gda?sk, Not set
Pratia Onkologia Katowice, Katowice, Not set
Uniwersytecki Szpital Kliniczny w Poznaniu, Pozna?, Not set
Hospital Universitari Vall d'Hebron, Barcelona, Not set
Hospital General Universitario Gregorio Marañon, Madrid, Not set
University College London Hospitals NHS Foundation Trust, London, Not set
Royal Marsden Hospital, Sutton, Not set
Conditions: Multiple Myeloma
Treatment of Acute Lymphoblastic Leukemia in Children
Completed
RATIONALE: L-asparaginase is an important component of treatment for childhood acute lymphoblastic leukemia, but is also associated with notable side-effects, including hypersensitivity, pancreatitis, and thrombosis. We have previously reported that patients with acute lymphoblastic leukemia in whom asparaginase treatment was discontinued because of intolerable side-effects had survival outcomes that were inferior to those who received all or nearly all of their intended doses. Two bacterial sou... Read More
RATIONALE: L-asparaginase is an important component of treatment for childhood acute lymphoblastic leukemia, but is also associated with notable side-effects, including hypersensitivity, pancreatitis, and thrombosis. We have previously reported that patients with acute lymphoblastic leukemia in whom asparaginase treatment was discontinued because of intolerable side-effects had survival outcomes that were inferior to those who received all or nearly all of their intended doses. Two bacterial sources of asparaginase exist: Escherichia coli (E coli) and Erwinia chrysanthemia (Erwinia). Generally, the E coli-derived enzyme has been used as front-line therapy and the Erwinia-derived preparation has been reserved for patients who develop hypersensitivity reactions. Pegylated E coli asparaginase (PEG-asparaginase) has a longer half-life and is potentially less immunogenic than native E coli L-asparaginase, and has been used as the initial asparaginase preparation in some pediatric acute lymphoblastic leukemia treatment regimens.
PURPOSE: Although the pharmacokinetics of each of these asparaginase preparations: intravenous PEG-asparaginase (IV-PEG) and intramuscular native E coli L-asparaginase (IM-EC) have been well characterized, their relative efficacy and toxicity have not been studied extensively. Read Less
Gender:
ALL
Ages:
Between 1 year and 18 years
Trial Updated:
07/08/2025
Locations: Dana Farber Cancer Institute, Boston, Massachusetts +7 locations
Dana Farber Cancer Institute, Boston, Massachusetts
Albert Einstein Cancer Center at Albert Einstein College of Medicine, Bronx, New York
Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, New York, New York
James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester, New York
Hasbro Children's Hospital, Providence, Rhode Island
McMaster Children's Hospital at Hamilton Health Sciences, Hamilton, Ontario
Hopital Sainte Justine, Montreal, Quebec
Centre de Recherche du Centre Hospitalier de l'Universite Laval, Sainte Foy, Quebec
Conditions: Drug/Agent Toxicity by Tissue/Organ, Leukemia
A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma
Not Yet Recruiting
The purpose of this study is to evaluate the preliminary safety and determine the RP2D of mezigdomide in combination with elranatamab in participants with relapsed and refractory multiple myeloma (RRMM).
The purpose of this study is to evaluate the preliminary safety and determine the RP2D of mezigdomide in combination with elranatamab in participants with relapsed and refractory multiple myeloma (RRMM). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/07/2025
Locations: Local Institution - 0001, Birmingham, Alabama +21 locations
Local Institution - 0001, Birmingham, Alabama
Local Institution - 0029, New Haven, Connecticut
Local Institution - 0028, Hackensack, New Jersey
Local Institution - 0005, Houston, Texas
Local Institution - 0032, Calgary, Alberta
Local Institution - 0026, Vancouver, British Columbia
Local Institution - 0027, Halifax, Nova Scotia
Local Institution - 0024, Toronto, Ontario
Local Institution - 0030, Suzhou, Jiangsu
Local Institution - 0031, Shanghai, Shanghai
Local Institution - 0015, Dresden, Not set
Local Institution - 0013, Hamburg, Not set
Local Institution - 0014, Heidelberg, Not set
Local Institution - 0011, Athens, Attikí
Local Institution - 0012, Athens, Attikí
Local Institution - 0017, Trondheim, Sør-Trøndelag
Local Institution - 0019, Oslo, Not set
Local Institution - 0021, Santander, Cantabria
Local Institution - 0022, Salamanca, Not set
Local Institution - 0016, London, England
Local Institution - 0018, London, Sutton
Local Institution - 0020, Manchester, Not set
Conditions: Multiple Myeloma
Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Active Not Recruiting
This is a multicenter, two-stage, randomized, controlled, open-label, Phase 3 study comparing the efficacy and safety of iberdomide in combination with dexamethasone and daratumumab (IberDd) versus daratumumab, bortezomib, and dexamethasone (DVd) in participants with relapsed or refractory multiple myeloma (RRMM).
This is a multicenter, two-stage, randomized, controlled, open-label, Phase 3 study comparing the efficacy and safety of iberdomide in combination with dexamethasone and daratumumab (IberDd) versus daratumumab, bortezomib, and dexamethasone (DVd) in participants with relapsed or refractory multiple myeloma (RRMM). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/07/2025
Locations: Local Institution - 035, Hot Springs, Arkansas +258 locations
Local Institution - 035, Hot Springs, Arkansas
Local Institution - 641, Cerritos, California
Local Institution - 681, Fountain Valley, California
Local Institution - 047, Los Angeles, California
Local Institution - 684, Newport, California
Local Institution - 033, New Haven, Connecticut
Local Institution - 029, Fort Myers, Florida
Local Institution - 693, Ocala, Florida
Local Institution - 028, Saint Petersburg, Florida
Local Institution - 045, Tamarac, Florida
Local Institution - 034, West Palm Beach, Florida
Local Institution - 685, Weston, Florida
Local Institution - 018, Atlanta, Georgia
Local Institution - 640, Elk Grove Village, Illinois
Local Institution - 697, Dyer, Indiana
Local Institution - 040, Louisville, Kentucky
Local Institution - 041, Alexandria, Louisiana
Local Institution - 682, Baton Rouge, Louisiana
Local Institution - 027, Baton Rouge, Louisiana
Local Institution - 698, Baltimore, Maryland
Local Institution - 014, Bethesda, Maryland
Local Institution - 688, Columbia, Maryland
Local Institution - 010, Boston, Massachusetts
Local Institution - 009, Worcester, Massachusetts
Local Institution - 645, Burnsville, Minnesota
Local Institution - 031, Kansas City, Missouri
Local Institution - 046, Billings, Montana
Local Institution - 015, Summit, New Jersey
Local Institution - 691, New York, New York
Local Institution - 039, Durham, North Carolina
Local Institution - 038, Cincinnati, Ohio
Local Institution - 037, Cleveland, Ohio
Local Institution - 008, Cleveland, Ohio
Local Institution - 036, Columbus, Ohio
Local Institution - 680, Tulsa, Oklahoma
Local Institution - 043, Portland, Oregon
Local Institution - 030, Chattanooga, Tennessee
Local Institution - 021, Nashville, Tennessee
Local Institution - 687, Austin, Texas
Local Institution - 695, Houston, Texas
Local Institution - 642, Newport News, Virginia
Local Institution - 643, Roanoke, Virginia
Local Institution - 025, Madison, Wisconsin
Local Institution - 080, Ciudad Autanoma De Buenos Aires, Buenos Aires
Local Institution - 083, Villa Elisa, Buenos Aires
Local Institution - 813, Birtinya, Queensland
Local Institution - 812, Douglas, Queensland
Local Institution - 803, Adelaide, South Australia
Local Institution - 806, Bedford Park, South Australia
Local Institution - 802, Clayton, Victoria
Local Institution - 809, East Melbourne, Victoria
Local Institution - 801, Melbourne, Victoria
Local Institution - 811, Murdoch, Western Australia
Local Institution - 807, West Perth, Western Australia
Local Institution - 804, Camperdown, Not set
Local Institution - 800, Fitzroy, Not set
Local Institution - 808, Garran, Not set
Local Institution - 155, Graz, Not set
Local Institution - 154, Linz, Not set
Local Institution - 153, Salzburg, Not set
Local Institution - 156, St Polten, Not set
Local Institution - 150, Vienna, Not set
Local Institution - 151, Wien, Not set
Local Institution - 172, Brugge, Not set
Local Institution - 174, Bruxelles, Not set
Local Institution - 056, Curitiba, Parana
Local Institution - 058, Porto Alegre, RIO Grande DO SUL
Local Institution - 050, Porto Alegre, RS
Local Institution - 054, Jau, SAO Paulo
Local Institution - 055, Sao Paulo, SP
Local Institution - 051, Barretos, São Paulo
Local Institution - 053, Rio de Janeiro, Not set
Local Institution - 057, Sao Paulo, Not set
Local Institution - 052, Sao Paulo, Not set
Local Institution - 111, Calgary, Alberta
Local Institution - 103, Edmonton, Alberta
Local Institution - 112, Surrey, British Columbia
Local Institution - 104, Saint John, New Brunswick
Local Institution - 110, St John's, Newfoundland and Labrador
Local Institution - 101, Halifax, Nova Scotia
Local Institution - 109, Ottawa, Quebec
Local Institution - 107, Saskatoon, Saskatchewan
Local Institution - 108, Quebec, Not set
Local Institution - 141, Changsha, Hunan
Local Institution - 129, Nanchang, Jiangxi
Local Institution - 143, Xian, Shaanxi
Local Institution - 142, Shanghai, Shanghai
Local Institution - 145, Taiyuan, Shanxi
Local Institution - 144, Wenzhou, Zhejiang
Local Institution - 140, Beijing, Not set
Local Institution - 139, Beijing, Not set
Local Institution - 138, Beijing, Not set
Local Institution - 126, Changchun, Not set
Local Institution - 121, Chaoyang District, Not set
Local Institution - 135, Guangzhou, Not set
Local Institution - 136, Guangzhou, Not set
Local Institution - 128, Hangzhou City, Not set
Local Institution - 120, Hangzhou, Zhejiang, Not set
Local Institution - 127, Harbin, Not set
Local Institution - 134, Nanjing, Not set
Local Institution - 132, Shanghai, Not set
Local Institution - 130, Shanghai, Not set
Local Institution - 131, Shenyang, Not set
Local Institution - 124, Suzhu, Not set
Local Institution - 133, Tianjin, Not set
Local Institution - 137, Wuhan, Not set
Local Institution - 125, Xian, Not set
Local Institution - 123, Zhengzhou, Not set
Local Institution - 601, Brno, Not set
Local Institution - 600, Ostrava-Poruba, Not set
Local Institution - 602, Prague 2, Not set
Local Institution - 371, Aalborg, Not set
Local Institution - 370, Odense, Not set
Local Institution - 372, Roskilde, Not set
Local Institution - 231, Turku, Varsinais-Suomi
Local Institution - 230, Helsinki, Not set
Local Institution - 232, Oulu, Not set
Local Institution - 463, Argenteuil, Not set
Local Institution - 462, La Roche -Sur-Yon - Cedex 9, Not set
Local Institution - 451, Lille Cedex, Not set
Local Institution - 458, Nancy Cedex, Not set
Local Institution - 454, Nantes, Not set
Local Institution - 452, Paris Cedex, Not set
Local Institution - 456, Paris, Not set
Local Institution - 464, Pessac, Not set
Local Institution - 465, Rouen, Not set
Local Institution - 457, Toulouse Cedex 9, Not set
Local Institution - 308, Kiel, Schleswig-Holstein
Local Institution - 301, Frankfurt am Main, Not set
Local Institution - 300, Hamburg, Not set
Local Institution - 302, Hamburg, Not set
Local Institution - 305, Heidelberg, Not set
Local Institution - 304, Lubeck, Not set
Local Institution - 573, Patras, Achaea
Local Institution - 574, Patra, Achaia
Local Institution - 571, Athens, Not set
Local Institution - 572, Thessaloniki, Not set
Local Institution - 570, Thessaloniki, Not set
Local Institution - 932, Hyderabad, Andhra Pradesh
Local Institution - 930, Bangalore, Karnataka
Local Institution - 934, Ernakulam, Kerala
Local Institution - 933, Mumbai, Maharashtra
Local Institution - 935, Kolkata, West Bengal
Local Institution - 931, Pondicherry, Not set
Local Institution - 752, Cork, Not set
Local Institution - 750, Dublin 9, Not set
Local Institution - 751, Galway, Not set
Local Institution - 874, Afula, HaZafon
Local Institution - 872, Haifa, Not set
Local Institution - 871, Jerusalem, Not set
Local Institution - 870, Tel Aviv, Not set
Local Institution - 873, Tel Hashomer, Not set
Local Institution - 415, Roma, Lazio
Local Institution - 400, Bologna, Not set
Local Institution - 408, Catania, Not set
Local Institution - 414, Genova, Not set
Local Institution - 404, Milano, Not set
Local Institution - 410, Novara, Not set
Local Institution - 412, Pavia, Not set
Local Institution - 402, Pisa, Not set
Local Institution - 405, Reggio Calabria, Not set
Local Institution - 401, Roma, Not set
Local Institution - 403, San Giovanni Rotondo FG, Not set
Local Institution - 406, Udine, Not set
Local Institution - 900, Matsuyama, Ehime
Local Institution - 917, Higashi-Ibaraki-gun, Ibaraki
Local Institution - 919, Shimotsuga, Tochigi
Local Institution - 920, Nerima-ku, Tokyo
Local Institution - 918, Shinagawa-ku, Tokyo
Local Institution - 915, Chuo-shi, Yamanashi
Local Institution - 912, Aomori, Not set
Local Institution - 916, Chiba, Not set
Local Institution - 911, Fukuoka, Not set
Local Institution - 903, Kamogawa, Not set
Local Institution - 902, Kyoto-City, Not set
Local Institution - 910, Nagoya, Not set
Local Institution - 901, Nagoya, Not set
Local Institution - 905, Okayama, Not set
Local Institution - 908, Osaka-Sayama, Not set
Local Institution - 907, Osaka, Not set
Local Institution - 913, Sapporo, Not set
Local Institution - 914, Sendai, Not set
Local Institution - 906, Shibuya-ku, Not set
Local Institution - 909, Shinagawa-ku, Tokyo, Not set
Local Institution - 904, Toyohashi, Not set
Local Institution - 974, Daegu, Not set
Local Institution - 973, Gyeonggi-do, Not set
Local Institution - 975, Hwasun-gun, Not set
Local Institution - 971, Seoul, Not set
Local Institution - 976, Seoul, Not set
Local Institution - 972, Seoul, Not set
Local Institution - 970, Seoul, Not set
Local Institution - 977, Seoul, Not set
Local Institution - 183, Guadalajara, Jalisco
Local Institution - 351, Dordrecht, Zuid-Holland
Local Institution - 354, Amsterdam, Not set
Local Institution - 352, Den Haag, Not set
Local Institution - 202, Bergen, Not set
Local Institution - 200, Oslo, Not set
Local Institution - 201, Trondheim, Not set
Local Institution - 631, Bialystok, Podlaskie
Local Institution - 633, Krakow, Not set
Local Institution - 635, Nowy Sacz, Not set
Local Institution - 634, Poznan, Not set
Local Institution - 636, Walbrzych, Not set
Local Institution - 630, Warszawa, Not set
Local Institution - 545, Coimbra, Not set
Local Institution - 543, Lisboa, Not set
Local Institution - 544, Lisboa, Not set
Local Institution - 540, Porto, Not set
Local Institution - 541, Porto, Not set
Local Institution - 514, Pamplona, Navarra
Local Institution - 505, Barcelona, Not set
Local Institution - 502, Barcelona, Not set
Local Institution - 511, Barcelona, Not set
Local Institution - 501, Caceres, Not set
Local Institution - 509, Cordoba, Not set
Local Institution - 510, Madrid, Not set
Local Institution - 516, Madrid, Not set
Local Institution - 504, Madrid, Not set
Local Institution - 513, Madrid, Not set
Local Institution - 503, Malaga, Not set
Local Institution - 508, Murcia, Not set
Local Institution - 506, Oviedo, Not set
Local Institution - 515, Salamanca, Not set
Local Institution - 500, Santiago de Compostela, Not set
Local Institution - 512, Valencia, Not set
Local Institution - 507, Zaragoza, Not set
Local Institution - 272, Boras, Not set
Local Institution - 271, Helsingborg, Not set
Local Institution - 851, Chur, Not set
Local Institution - 850, St. Gallen, Not set
Local Institution - 955, Niao-Sung Hsiang Kaohsiung County, Not set
Local Institution - 952, Taichung City, Not set
Local Institution - 954, Taichung, Not set
Local Institution - 951, Tainan, Taiana, Not set
Local Institution - 956, Taipei, Zhongzheng Dist., Not set
Local Institution - 950, Taipei, Not set
Local Institution - 953, Taoyuan City, Not set
Local Institution - 778, Kavaklıdere, Ankara
Local Institution - 776, Yenimahalle, Ankara
Local Institution - 777, Pendik, Istanbul
Local Institution - 771, Balçova, Izmir
Local Institution - 775, Bornova, Izmir
Local Institution - 773, Samsun, Kurupelit
Local Institution - 770, Ankara, Not set
Local Institution - 772, Gaziantep, Not set
Local Institution - 774, Kayseri, Not set
Local Institution - 702, Nottingham, Nottinghamshire
Local Institution - 705, Belfast Northern Ireland, Not set
Local Institution - 700, Birmingham, Not set
Local Institution - 707, Canterbury Kent, Not set
Local Institution - 704, Lancashire Blackpool, Not set
Local Institution - 701, London, Not set
Local Institution - 709, London, Not set
Local Institution - 706, Oxford, Not set
Local Institution - 711, Portsmouth, Not set
Local Institution - 713, Sutton, Not set
Local Institution - 708, Wolverhampton, Not set
Conditions: Multiple Myeloma
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
Recruiting
A Phase I study to evaluate the safety of a novel, orally available, selective, and potent small molecule inhibitor of the histone lysine methyl transferase MMSET (also known as NSD2/WHSC1) to prevent the dimethylation of H3K36 in adult patients with relapsed or refractory multiple myeloma (RRMM).
A Phase I study to evaluate the safety of a novel, orally available, selective, and potent small molecule inhibitor of the histone lysine methyl transferase MMSET (also known as NSD2/WHSC1) to prevent the dimethylation of H3K36 in adult patients with relapsed or refractory multiple myeloma (RRMM). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/07/2025
Locations: UCSF Medical Center - Hematology and Blood and Marrow Transplant Clinic, San Francisco, California +20 locations
UCSF Medical Center - Hematology and Blood and Marrow Transplant Clinic, San Francisco, California
Mayo Clinic Hospital - Florida, Jacksonville, Florida
The Winship Cancer Institute of Emory University, Atlanta, Georgia
Massachusetts General Hospital, Boston, Massachusetts
Mayo Clinic - Transplant Center - Rochester, Rochester, Minnesota
Hackensack University Medical Center, Hackensack, New Jersey
Memorial Sloan-Kettering Cancer Center, New York, New York
Atrium Health, Levine Cancer Institute, Charlotte, North Carolina
Duke University Hospital, Durham, North Carolina
University of Pennsylvania, Philadelphia, Pennsylvania
Tennessee Oncology, Nashville, Tennessee
University of Texas Southwestern Harold C. Simmons Comprehensive Cancer Center, Dallas, Texas
University Health Network (UHN) - Princess Margaret Cancer Centre (Princess Margaret Hospital), Toronto, Ontario
Centre Hospitalier Universitaire de Nantes (CHU de Nantes) - Hotel-Dieu, Nantes, Not set
Centre Hospitalier Universitaire de Poitiers (CHU de Poitiers), Poitiers, Not set
Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, Not set
Universitaire de Lille, Villeneuve-d'Ascq, Not set
Clínica Universidad de Navarra, Pamplona, Navarra
Hospital ClÃ-nic de Barcelona, Barcelona, Not set
Hospital Universitario 12 de Octubre, Madrid, Not set
Instituto de Investigacion Biomedica de Salamanca (IBSAL), Salamanca, Not set
Conditions: Multiple Myeloma, Myeloma, Myeloma Multiple
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Active Not Recruiting
This is a phase 3, randomized, open-label study of opevesostat compared to alternative abiraterone acetate or enzalutamide in participants with metastatic castration-resistant prostate cancer (mCRPC) with respect to overall survival (OS) and to radiographic progression-free survival (rPFS) per Prostate Cancer Working Group (PCWG) Modified Response Evaluation Criteria In Solid Tumors (RECIST 1.1) as assessed by blinded independent central review (BICR) in participants with mCRPC previously treate... Read More
This is a phase 3, randomized, open-label study of opevesostat compared to alternative abiraterone acetate or enzalutamide in participants with metastatic castration-resistant prostate cancer (mCRPC) with respect to overall survival (OS) and to radiographic progression-free survival (rPFS) per Prostate Cancer Working Group (PCWG) Modified Response Evaluation Criteria In Solid Tumors (RECIST 1.1) as assessed by blinded independent central review (BICR) in participants with mCRPC previously treated with next-generation hormonal agent (NHA) and taxane-based chemotherapy. It is hypothesized that opevesostat is superior with respect to OS and rPFS per PCWG Modified RECIST 1.1 as assessed by BICR in androgen receptor ligand binding domain (AR LBD) mutation-negative and -positive participants. Read Less
Gender:
ALL
Ages:
All
Trial Updated:
07/03/2025
Locations: University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 0040), Orange, California +278 locations
University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 0040), Orange, California
Stanford Cancer Center ( Site 0036), Palo Alto, California
Kaiser Permanente Riverside Medical Center ( Site 0099), Riverside, California
Anschutz Cancer Pavilion ( Site 0046), Aurora, Colorado
University of Colorado Health - Highlands Ranch Hospital ( Site 0111), Highlands Ranch, Colorado
Colorado Clinical Research ( Site 0067), Lakewood, Colorado
University of Colorado Health - Lone Tree Medical Center ( Site 0112), Lone Tree, Colorado
Yale-New Haven Hospital-Yale Cancer Center ( Site 0064), New Haven, Connecticut
Florida Cancer Specialists - South ( Site 7003), Fort Myers, Florida
Bruce W. Carter Veterans Affairs Medical Center ( Site 0082), Miami, Florida
University of Miami Hospital and Clinics, Sylvester Cancer Center ( Site 0051), Miami, Florida
University of Illinois at Chicago ( Site 0105), Chicago, Illinois
University of Chicago Medical Center ( Site 0045), Chicago, Illinois
University of Iowa ( Site 0047), Iowa City, Iowa
University of Kentucky Chandler Medical Center ( Site 0048), Lexington, Kentucky
Ochsner Clinic Foundation ( Site 0108), New Orleans, Louisiana
Baltimore Veterans Affairs Medical Center ( Site 0069), Baltimore, Maryland
Greenebaum Comprehensive Cancer Center ( Site 0049), Baltimore, Maryland
Henry Ford Hospital ( Site 0015), Detroit, Michigan
M Health Fairview Clinics and Surgery Center ( Site 0019), Minneapolis, Minnesota
Metro-Minnesota Community Clinical Oncology ( Site 0014), Saint Louis Park, Minnesota
Washington University School of Medicine-Internal Medicine/Oncology ( Site 0062), Saint Louis, Missouri
University Of Nebraska Medical Center-Oncology/Hematology ( Site 0095), Omaha, Nebraska
Comprehensive Cancer Centers of Nevada ( Site 0010), Las Vegas, Nevada
Atlantic Health System Morristown Medical Center ( Site 0115), Morristown, New Jersey
Rutgers Cancer Institute of New Jersey ( Site 0033), New Brunswick, New Jersey
James J. Peters VA Medical Center ( Site 0088), Bronx, New York
University Hospitals Cleveland Medical Center ( Site 0043), Cleveland, Ohio
Oregon Health and Science University ( Site 0028), Portland, Oregon
VA Portland Health Care System ( Site 0058), Portland, Oregon
AHN Allegheny General Hospital ( Site 0001), Pittsburgh, Pennsylvania
Ralph H. Johnson VA Health Care System (RHJVAHCS)-Urology ( Site 0083), Charleston, South Carolina
Avera Cancer Institute - Pierre ( Site 0118), Pierre, South Dakota
Avera Cancer Institute- Research ( Site 0094), Sioux Falls, South Dakota
Avera Cancer Institute - Yankton ( Site 0117), Yankton, South Dakota
SCRI Oncology Partners ( Site 7000), Nashville, Tennessee
Texas Oncology - Central/South Texas ( Site 8003), Austin, Texas
Texas Oncology - DFW ( Site 8001), Dallas, Texas
Texas Oncology - Gulf Coast ( Site 8002), The Woodlands, Texas
University of Virginia Health System ( Site 0054), Charlottesville, Virginia
VCU Health Adult Outpatient Pavillion ( Site 0061), Richmond, Virginia
Blue Ridge Cancer Care ( Site 0004), Roanoke, Virginia
Fred Hutchinson Cancer Center ( Site 0013), Seattle, Washington
MEDICAL COLLEGE OF WISCONSIN ( Site 0020), Milwaukee, Wisconsin
Hospital Británico de Buenos Aires-Oncology ( Site 0202), Ciudad autónoma de Buenos Aires, Buenos Aires
Instituto de Investigaciones Clínicas Mar del Plata ( Site 0201), Mar del Plata, Buenos Aires
Asociación de Beneficencia Hospital Sirio Libanés ( Site 0205), Buenos Aires, Caba
Instituto Alexander Fleming-Alexander Fleming ( Site 0206), Ciudad Autónoma de Buenos Aires, Caba
Sanatorio Parque ( Site 0208), Rosario, Santa Fe
Hospital Aleman-Oncology ( Site 0207), Buenos Aires, Not set
Fundacion Centro Oncologico de Integración Regional-Medical Oncology ( Site 0204), Mendoza, Not set
Dubbo Hospital ( Site 0235), Dubbo, New South Wales
Macquarie University-MQ Health Clinical Trials Unit ( Site 0234), Macquarie University, New South Wales
Westmead Hospital ( Site 0232), Westmead, New South Wales
Princess Alexandra Hospital-Cancer Care Serices ( Site 0237), Brisbane, Queensland
Peter MacCallum Cancer Centre-Parkville Cancer Clinical Trials Unit (PCCTU) ( Site 0230), Melbourne, Victoria
Ordensklinikum Linz GmbH Elisabethinen-Urologie ( Site 0276), Linz, Oberosterreich
Klinikum Wels-Grieskirchen GmbH ( Site 0279), Wels, Oberosterreich
Medizinische Universität Graz-Innere Medizin Klin. Abt. Onkologie ( Site 0280), Graz, Steiermark
Obras Sociais Irma Dulce ( Site 0302), Salvador, Bahia
Hospital Santa Rita de Cassia-Centro de Pesquisa Clínica ( Site 0320), Vitoria, Espirito Santo
Hospital Felicio Rocho ( Site 0317), Belo Horizonte, Minas Gerais
Hospital Mario Penna ( Site 0309), Belo Horizonte, Minas Gerais
Hospital Universitário Evangélico Mackenzie-Centro de Oncologia Mackenzie ( Site 0314), Curitiba, Parana
Clínica de Neoplasias Litoral ( Site 0305), Itajai, Santa Catarina
Hospital Universitário São Francisco de Assis - Bragança Paulista ( Site 0308), Bragança Paulista, Sao Paulo
A. C. Camargo Cancer Center ( Site 0310), São Paulo, Sao Paulo
Cross Cancer Institute ( Site 0332), Edmonton, Alberta
The Ottawa Hospital - General Campus-The Ottawa Hospital Cancer Centre ( Site 0336), Ottawa, Ontario
Sunnybrook Research Institute ( Site 0331), Toronto, Ontario
Princess Margaret Cancer Centre ( Site 0330), Toronto, Ontario
Centre Intégré de Santé et de Services Sociaux de la Montérégie-Centre ( Site 0328), Greenfield Park, Quebec
Centre Hospitalier de l'Université de Montréal ( Site 0326), Montréal, Quebec
Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 0327), Quebec City, Quebec
Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Univer ( Site 0329), Sherbrooke, Quebec
IC La Serena Research ( Site 0356), La Serena., Coquimbo
Clinical Research Chile SpA ( Site 0358), Valdivia, Los Rios
Clinica Universidad Catolica del Maule-Oncology ( Site 0355), Talca, Maule
FALP ( Site 0353), Santiago, Region M. De Santiago
Pontificia Universidad Catolica de Chile-Hemato-Oncology ( Site 0354), Santiago, Region M. De Santiago
Bradfordhill-Clinical Area ( Site 0351), Santiago, Region M. De Santiago
Bradford Hill Norte ( Site 0357), Antofagasta, Not set
Second Affiliated hospital of Anhui Medical University-Urology ( Site 0408), Hefei, Anhui
Peking University First Hospital-Urology ( Site 0390), Beijing, Beijing
Beijing Friendship Hospital Affiliate of Capital University ( Site 0396), Beijing, Beijing
Beijing Cancer hospital-Urinary Surgery ( Site 0395), Beijing, Beijing
The First Affiliated Hospital of Chongqing Medical University ( Site 0427), Chongqing, Chongqing
Chongqing University Cancer Hospital ( Site 0416), Chongqing, Chongqing
Southwest Hospital of Third Military Medical University ( Site 0420), Chongqing, Chongqing
Chongqing Three Gorges Central Hospital's ( Site 0426), Chongqing, Chongqing
The First Affiliated Hospital Of Fujian Medical University-Urology ( Site 0414), Fuzhou, Fujian
The First Affiliated hospital of Xiamen University-Urology ( Site 0415), Xiamen, Fujian
The First Affiliated Hospital of Guangzhou Medical University ( Site 0412), Guangzhou, Guangdong
Sun Yat-sen University Cancer Center-Internal medicine ( Site 0413), Guangzhou, Guangdong
Tongji Hospital Tongji Medical,Science & Technology ( Site 0407), Wuhan, Hubei
Hubei Cancer Hospital-Urinary surgery ( Site 0406), Wuhan, Hubei
Hunan Cancer Hospital ( Site 0405), Changsha, Hunan
First Huai'an Hospital Affiliated to Nanjing Medical University ( Site 0436), Huaian, Jiangsu
Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Urology ( Site 0377), NanJing, Jiangsu
Affiliated hospital of Jiangnan university ( Site 0434), Wuxi, Jiangsu
Jiangxi Cancer Hospital ( Site 0386), Nanchang, Jiangxi
The Second Affiliated Hospital of Xi'an Jiaotong University ( Site 0394), XI An, Shaanxi
The First Affiliated Hospital of Xi'an Jiaotong University-Oncology ( Site 0393), Xi'an, Shaanxi
Yantai Yuhuangding Hospital ( Site 0397), Yantai, Shandong
Fudan University Shanghai Cancer Center-Urology department ( Site 0376), Shanghai, Shanghai
Huadong Hospital Affiliated to Fudan University-Urology ( Site 0388), Shanghai, Shanghai
West China Hospital, Sichuan University-Urology Surgery ( Site 0417), Cheng Du, Sichuan
The Third People's Hospital of Chengdu (CDTPH) ( Site 0428), Chengdu, Sichuan
Nanchong Central Hospital-urology ( Site 0422), Nanchong, Sichuan
Suining Central Hospital ( Site 0437), Suining, Sichuan
Tianjin Medical University Cancer Institute & Hospital ( Site 0392), Tianjin, Tianjin
The Second Hospital of Tianjin Medical University ( Site 0391), Tianjin, Tianjin
Xinjiang Medical University Cancer Hospital - Urumqi-Urology ( Site 0419), Urumqi, Xinjiang
The Second Affiliated Hospital Of Kunming Medical University ( Site 0429), Kunming, Yunnan
Yunnan Province Cancer Hospital ( Site 0418), Kunming, Yunnan
Zhejiang Provincial People's Hospital-Urology ( Site 0378), Hangzhou, Zhejiang
Zhejiang Cancer Hospital ( Site 0435), Hangzhou, Zhejiang
The First Hospital of Jiaxing-urology ( Site 0380), Jiaxing, Zhejiang
The First Affiliated Hospital of Ningbo University ( Site 0383), Ningbo, Zhejiang
The First Affiliated Hospital of Wenzhou Medical University-Urology Surgery ( Site 0379), Wenzhou, Zhejiang
Sociedad De Oncología y Hematología Del Cesar SAS-Oncology ( Site 0502), Valledupar, Cesar
IMAT S.A.S ( Site 0504), Monteria, Cordoba
Clinica Colsanitas S.A, Sede Clínica Universitaria Colombia-Center Investigator ( Site 0501), Bogota, Distrito Capital De Bogota
Fundación Cardiovascular de Colombia ( Site 0503), Piedecuesta, Santander
Fundación Valle del Lili ( Site 0505), Cali, Valle Del Cauca
Clínica Imbanaco S.A.S ( Site 0509), Cali, Valle Del Cauca
Masarykuv onkologicky ustav-Klinika komplexni onkologicke pece ( Site 0553), Brno, Brno-mesto
Fakultni nemocnice Ostrava-Klinika onkologicka ( Site 0554), Ostrava, Moravskoslezsky Kraj
Fakultni nemocnice Olomouc-Onkologicka klinika ( Site 0555), Olomouc, Olomoucky Kraj
Fakultni nemocnice v Motole-Onkologicka klinika 2. LF UK a FN Motol ( Site 0551), Praha, Praha 5
Rigshospitalet ( Site 0576), Copenhagen, Hovedstaden
Odense Universitetshospital-Department of oncology ( Site 0579), Odense, Syddanmark
Vejle Sygehus ( Site 0578), Vejle, Syddanmark
Tampereen yliopistollinen sairaala ( Site 0604), Tampere, Pirkanmaa
Kuopion Yliopistollinen Sairaala ( Site 0603), Kuopio, Pohjois-Savo
Turku University Hospital-Department of Oncology ( Site 0601), Turku, Varsinais-Suomi
Institut de cancérologie Strasbourg Europe (ICANS) ( Site 0627), Strasbourg, Alsace
Centre Hospitalier Universitaire de Nîmes - Institut de Cancérologie du Gard - Hôpital Universitaire ( Site 0630), Nîmes, Gard
Centre Eugène Marquis Rennes - Centre de Lutte Contre le Cancer ( Site 0632), Rennes, Ille-et-Vilaine
Centre Jean Perrin - Centre Régional de Lutte contre le Cancer d'Auvergne ( Site 0629), Clermont-Ferrand, Puy-de-Dome
Centre Hospitalier de la Côte Basque ( Site 0633), Bayonne, Pyrenees-Atlantiques
Gustave Roussy ( Site 0626), Villejuif, Val-de-Marne
Hôpital Européen Georges Pompidou ( Site 0628), Paris, Not set
klinikum rechts der isar der technischen universität münchen-Urologische Klinik und Poliklinik ( Site 0696), Munich, Bayern
HELIOS Kliniken Schwerin ( Site 0694), Schwerin, Mecklenburg-Vorpommern
Universitätsklinikum Bonn-Klinik und Poliklinik für Urologie und Kinderurologie ( Site 0680), Bonn, Nordrhein-Westfalen
Universitätsklinikum Münster - Albert Schweitzer Campus-Klinik für Urologie ( Site 0678), Münster, Nordrhein-Westfalen
Universitätsklinikum Schleswig-Holstein-Klinik für Urologie ( Site 0691), Lubeck, Schleswig-Holstein
Universitätsklinikum Jena-Klinik und Poliklinik für Urologie ( Site 0682), Jena, Thuringen
Charité Universitaetsmedizin Berlin - Campus Mitte ( Site 0679), Berlin, Not set
Universitaetsklinikum Hamburg-Eppendorf-Onkologisches Zentrum ( Site 0705), Hamburg, Not set
Queen Mary Hospital ( Site 0727), Hong Kong, Not set
Prince of Wales Hospital ( Site 0730), Shatin, Not set
Bacs-Kiskun Varmegyei Oktatokorhaz-Onkoradiologiai Kozpont ( Site 0752), Kecskemét, Bacs-Kiskun
Nograd Varmegyei Szent Lazar Korhaz-Onkologia es Sugarterapias Osztaly ( Site 0761), Salgótarján, Nograd
Országos Onkológiai Intézet-Urogenitális Tumorok és Klinikai Farmakológiai Osztály ( Site 0756), Budapest, Pest
Debreceni Egyetem Klinikai Kozpont-Onkológiai Klinika ( Site 0758), Debrecen, Not set
St. Vincent's University Hospital ( Site 0802), Dublin 04, Dublin
Tallaght University Hospital ( Site 0801), Dublin, Not set
Emek Medical Center ( Site 0830), Afula, Not set
Rambam Health Care Campus-Oncology Division ( Site 0826), Haifa, Not set
Hadassah Medical Center ( Site 0833), Jerusalem, Not set
Meir Medical Center. ( Site 0832), Kfar Saba, Not set
Rabin Medical Center ( Site 0828), Petah Tikva, Not set
Sheba Medical Center ( Site 0827), Ramat Gan, Not set
IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori"-Oncologia Medica ( Site 0879), Meldola, Emilia-Romagna
Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 0877), Milan, Lombardia
Ospedale San Raffaele-Oncologia Medica ( Site 0876), Milano, Not set
Toho University Sakura Medical Center ( Site 0906), Sakura, Chiba
Ehime University Hospital ( Site 0918), Toon, Ehime
Hospital of the University of Occupational and Environmental Health, Japan ( Site 0921), Kitakyushu, Fukuoka
Kurume University Hospital ( Site 0920), Kurume, Fukuoka
Asahikawa Medical University Hospital ( Site 0901), Asahikawa, Hokkaido
Sapporo Medical University Hospital ( Site 0902), Sapporo, Hokkaido
Hokkaido University Hospital ( Site 0931), Sapporo, Hokkaido
Kobe University Hospital ( Site 0914), Kobe, Hyogo
Kanazawa Medical University Hospital ( Site 0909), Uchinada, Ishikawa
Kagawa University Hospital ( Site 0917), Kita, Kagawa
Yokohama City University Medical Center ( Site 0908), Yokohama, Kanagawa
National Hospital Organization Nagasaki Medical Center ( Site 0923), Ōmura, Nagasaki
Nara Medical University Hospital ( Site 0915), Kashihara, Nara
Nanbu Tokushukai Hospital ( Site 0930), Shimajiri, Okinawa
Kansai Medical University Hospital ( Site 0912), Hirakata, Osaka
Bell Land General Hospital ( Site 0913), Sakai, Osaka
The University of Osaka Hospital ( Site 0911), Suita, Osaka
Saga-Ken Medical Centre Koseikan ( Site 0922), Saga-shi, Saga
The Jikei University Hospital ( Site 0907), Minato, Tokyo
Akita University Hospital ( Site 0904), Akita, Not set
Kyushu University Hospital ( Site 0919), Fukuoka, Not set
Fukushima Medical University Hospital ( Site 0933), Fukushima, Not set
Gifu University Hospital ( Site 0910), Gifu, Not set
Hiroshima University Hospital ( Site 0916), Hiroshima, Not set
Kagoshima University Hospital ( Site 0929), Kagoshima, Not set
National Hospital Organization Kumamoto Medical Center ( Site 0924), Kumamoto, Not set
Miyazaki Prefectural Miyazaki Hospital ( Site 0927), Miyazaki, Not set
University of Miyazaki Hospital ( Site 0926), Miyazaki, Not set
Nagano Municipal Hospital ( Site 0932), Nagano, Not set
National Hospital Organization Oita Medical Center ( Site 0925), Oita, Not set
Asan Medical Center-Oncology ( Site 1402), Songpagu, Seoul
Seoul National University Hospital-Oncology ( Site 1401), Seoul, Not set
Severance Hospital, Yonsei University Health System-Medical oncology ( Site 1404), Seoul, Not set
Samsung Medical Center ( Site 1405), Seoul, Not set
Hospital Sultan Ismail ( Site 1081), Johor Bahru, Johor
University Malaya Medical Centre ( Site 1077), Lembah Pantai, Kuala Lumpur
Sarawak General Hospital-Radiotherapy Unit ( Site 1076), Kuching, Sarawak
National Cancer Institute ( Site 1079), Putrajaya, Wilayah Persekutuan Putrajaya
Hospital Kuala Lumpur-Radiotherapy and Oncology ( Site 1078), Kuala Lumpur, Not set
Quemex Medical and Research ( Site 1112), Mexico City, Distrito Federal
CIO - Centro de Inmuno-Oncología de Occidente ( Site 1103), Guadalajara, Jalisco
Filios Alta Medicina ( Site 1106), Monterrey, Nuevo Leon
Medical Care and Research SA de CV ( Site 1108), Merida, Yucatan
Centro de Investigacion Clinica de Oaxaca ( Site 1109), Oaxaca, Not set
Medische Centrum Leeuwarden ( Site 1172), Leeuwarden, Fryslan
Radboudumc-Medical Oncology ( Site 1152), Nijmegen, Gelderland
Zuyderland Medical Centre-Trialbureau Interne Geneeskunde ( Site 1163), Sittard-Geleen, Limburg
VieCuri Medisch Centrum ( Site 1173), Venlo, Limburg
ETZ Elisabeth-Internal Medicine ( Site 1160), Tilburg, Noord-Brabant
Nederlands Kanker Instituut - Antoni van Leeuwenhoek - NKI-AVL ( Site 1153), Amsterdam, Noord-Holland
Amsterdam UMC, locatie VUmc ( Site 1156), Amsterdam, Noord-Holland
Spaarne Gasthuis - Hoofddorp-Oncology ( Site 1170), Hoofddorp, Noord-Holland
Meander Medisch Centrum ( Site 1157), Amersfoort, Utrecht
Haga Ziekenhuis locatie Leyweg-Oncology ( Site 1164), Den Haag, Zuid-Holland
Franciscus Gasthuis & Vlietland, Locatie Vlietland ( Site 1151), Schiedam, Zuid-Holland
Tauranga Hospital-Bay of Plenty Clinical Trials Unit ( Site 1201), Tauranga, Bay Of Plenty
Dunedin Hospital-Southern Blood and Cancers Service ( Site 1203), Dunedin, Otago
Akershus Universitetssykehus-Onkologisk avdeling ( Site 1227), Lørenskog, Akershus
Sykehuset Østfold Kalnes ( Site 1228), Sarpsborg, Ostfold
St. Olavs Hospital-Kreftklinikken ( Site 1231), Trondheim, Sor-Trondelag
Instituto Regional de Enfermedades Neoplasicas del Centro (IREN CENTRO) ( Site 1258), Concepcion, Junin
Clínica Sánchez Ferrer ( Site 1261), Trujillo, La Libertad
Aliada-Oncologìa ( Site 1257), Lima, Not set
IPOR Instituto Peruano de Oncología & Radioterapia-Centro de Investigación ( Site 1254), Lima, Not set
Oncosalud-Clinical Research ( Site 1260), Lima, Not set
INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS-Medical Oncology ( Site 1256), Lima, Not set
Centrum Onkologii im. Prof. Franciszka Lukaszczyka-Ambulatorium Chemioterapii ( Site 1302), Bydgoszcz, Kujawsko-pomorskie
Regionalny Szpital Specjalistyczny im. dr. Władyslawa Biegańskiego ( Site 1316), Grudziadz, Kujawsko-pomorskie
Wojewodzki Szpital Zespolony im Ludwika Rydygiera w Toruniu ( Site 1304), Torun, Kujawsko-pomorskie
Mazowiecki Szpital Wojewódzki w Siedlcach-Siedleckie Centrum Onkologii ( Site 1310), Siedlce, Mazowieckie
Swietokrzyskie Centrum Onkologii, Samodzielny Publiczny Zakl-Klinika Onkologii Klinicznej, Dzial Ch ( Site 1318), Kielce, Swietokrzyskie
Szpital Wojewódzki im. Mikoaja Kopernika w Koszalinie-Oddzial Dzienny Chemioterapii ( Site 1303), Koszalin, Zachodniopomorskie
Zachodniopomorskie Centrum Onkologii ( Site 1311), Szczecin, Zachodniopomorskie
Puerto Rico Medical Research Center LLC ( Site 1354), Hato Rey, Not set
Ad-Vance Medical Research-Research ( Site 1353), Ponce, Not set
Pan American Center for Oncology Trials - Ciudadela ( Site 1351), San Juan, Not set
National University Hospital ( Site 1376), Singapore, Central Singapore
National Cancer Centre Singapore ( Site 1377), Singapore, Central Singapore
Tan Tock Seng Hospital-Medical Oncology ( Site 1378), Singapore, Central Singapore
Hospital Jerez de la Frontera ( Site 1427), Jerez de la Frontera, Cadiz
Hospital Universitario Ramón y Cajal-Medical Oncology ( Site 1431), Madrid, Madrid, Comunidad De
Hospital Universitario 12 de Octubre-Medical Oncology ( Site 1433), Madrid, Madrid, Comunidad De
Complexo Hospitalario Universitario de Ourense ( Site 1426), Ourense, Orense
Fundación Instituto Valenciano de Oncología-Oncologico ( Site 1430), Valencia, Valenciana, Comunitat
Hospital Lucus Augusti-Oncology ( Site 1432), Lugo, Not set
HOSPITAL UNIVERSITARIO VIRGEN DEL ROCIO-Medical Oncology ( Site 1428), Sevilla, Not set
Karolinska Universitetssjukhuset Solna ( Site 1478), Stockholm, Stockholms Lan
Akademiska sjukhuset-Blod- och tumörsjukdomar ( Site 1477), Uppsala, Uppsala Lan
Sahlgrenska Universitetssjukhuset ( Site 1479), Gothenburg, Vastra Gotalands Lan
China Medical University Hospital-Department of Urology ( Site 1503), Taichung, Not set
National Cheng Kung University Hospital-Urology ( Site 1502), Tainan, Not set
National Taiwan University Hospital-Urology ( Site 1506), Taipei, Not set
Taipei Veterans General Hospital ( Site 1505), Taipei, Not set
Chang Gung Medical Foundation-Linkou Branch-Medical Oncology ( Site 1504), Taoyuan, Not set
Faculty of Medicine - Khon Kaen University ( Site 1526), Muang, Khon Kaen
Chulalongkorn University ( Site 1530), Bangkok, Krung Thep Maha Nakhon
Faculty of Medicine Siriraj Hospital ( Site 1531), Bangkok, Krung Thep Maha Nakhon
Songklanagarind hospital ( Site 1527), Hatyai, Songkhla
Baskent University Dr. Turgut Noyan Research and Training Center-ONCOLOGY ( Site 1554), Adana, Not set
Gulhane Egitim Arastirma Hastanesi ( Site 1558), Ankara, Not set
Hacettepe Universite Hastaneleri-oncology hospital ( Site 1551), Ankara, Not set
Memorial Ankara Hastanesi-Medical Oncology ( Site 1557), Ankara, Not set
Ankara Bilkent Şehir Hastanesi-Medical Oncology ( Site 1552), Ankara, Not set
Istanbul Universitesi Cerrahpasa-Medical Oncology ( Site 1555), Istanbul, Not set
TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 1553), Istanbul, Not set
Addenbrooke's Hospital ( Site 1605), Cambridge, Cambridgeshire
The Royal Cornwall Hospital ( Site 1610), Truro, England
The Beatson West of Scotland Cancer Centre ( Site 1603), Glasgow, Glasgow City
Charing Cross Hospital-Oncology Research ( Site 1606), London, Hammersmith And Fulham
University College London Hospital ( Site 1612), London, London, City Of
The Christie NHS Foundation Trust ( Site 1608), Manchester, Not set
Conditions: Prostate Cancer Metastatic
Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents
Active Not Recruiting
Acute lymphoblastic leukemia (ALL) is the most common cancer diagnosed in children. The cancer comes from a cell in the blood called a lymphocyte. Normal lymphocytes are produced in the bone marrow (along with other blood cells) and help fight infections. In ALL, the cancerous lymphocytes are called lymphoblasts. They do not help fight infection and crowd out the normal blood cells in the bone marrow so that the body cannot make enough normal blood cells. ALL is always fatal if it is not treated... Read More
Acute lymphoblastic leukemia (ALL) is the most common cancer diagnosed in children. The cancer comes from a cell in the blood called a lymphocyte. Normal lymphocytes are produced in the bone marrow (along with other blood cells) and help fight infections. In ALL, the cancerous lymphocytes are called lymphoblasts. They do not help fight infection and crowd out the normal blood cells in the bone marrow so that the body cannot make enough normal blood cells. ALL is always fatal if it is not treated. With current treatments, most children and adolescents with this disease will be cured.
The standard treatment for ALL involves about 2 years of chemotherapy. The drugs that are used, and the doses of the drugs, are similar but not identical for all children and adolescents with ALL. Some children and adolescents receive stronger treatment, especially during the first several months. A number of factors are used to decide how strong the treatment should be to give the best chance for cure. These factors are called "risk factors". This trial is studying the use of a new, updated set of risk factors to decide how strong the treatment will be. The study also will test a new way of dosing a chemotherapy drug called pegaspargase (which is part of the standard treatment for ALL) based on checking levels of the drug in the blood and adjusting the dose based on the levels. Read Less
Gender:
ALL
Ages:
Between 1 year and 21 years
Trial Updated:
07/01/2025
Locations: Boston Children's Hospital, Boston, Massachusetts +8 locations
Boston Children's Hospital, Boston, Massachusetts
Dana-Farber Cancer Institute, Boston, Massachusetts
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey
Montefiore Medical Center, Bronx, New York
Roswell Park Cancer Institute, Buffalo, New York
Columbia University Medical Center, Morgan Stanley Children's Hospital of New York-Presbyterian, New York, New York
Hasbro Children's Hospital / Rhode Island Hospital, Providence, Rhode Island
Hospital Sainte Justine, University of Montreal, Montreal, Quebec
Centre Hospitalier U. de Quebec, Quebec City, Quebec
Conditions: Acute Lymphoblastic Leukemia, Pediatric
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Recruiting
This phase II trial studies the effect of nivolumab in combination with blinatumomab compared to blinatumomab alone in treating patients with B-cell acute lymphoblastic leukemia (B-ALL) that has come back (relapsed). Down syndrome patients with relapsed B-ALL are included in this study. Blinatumomab is an antibody, which is a protein that identifies and targets specific molecules in the body. Blinatumomab searches for and attaches itself to the cancer cell. Once attached, an immune response occu... Read More
This phase II trial studies the effect of nivolumab in combination with blinatumomab compared to blinatumomab alone in treating patients with B-cell acute lymphoblastic leukemia (B-ALL) that has come back (relapsed). Down syndrome patients with relapsed B-ALL are included in this study. Blinatumomab is an antibody, which is a protein that identifies and targets specific molecules in the body. Blinatumomab searches for and attaches itself to the cancer cell. Once attached, an immune response occurs which may kill the cancer cell. Nivolumab is a medicine that may boost a patient's immune system. Giving nivolumab in combination with blinatumomab may cause the cancer to stop growing for a period of time, and for some patients, it may lessen the symptoms, such as pain, that are caused by the cancer. Read Less
Gender:
ALL
Ages:
Between 1 year and 30 years
Trial Updated:
07/01/2025
Locations: Children's Hospital of Alabama, Birmingham, Alabama +207 locations
Children's Hospital of Alabama, Birmingham, Alabama
USA Health Strada Patient Care Center, Mobile, Alabama
Providence Alaska Medical Center, Anchorage, Alaska
Kingman Regional Medical Center, Kingman, Arizona
Banner Children's at Desert, Mesa, Arizona
Banner University Medical Center - Tucson, Tucson, Arizona
Arkansas Children's Hospital, Little Rock, Arkansas
Kaiser Permanente-Anaheim, Anaheim, California
PCR Oncology, Arroyo Grande, California
Kaiser Permanente-Bellflower, Bellflower, California
Kaiser Permanente Downey Medical Center, Downey, California
City of Hope Comprehensive Cancer Center, Duarte, California
Kaiser Permanente-Fontana, Fontana, California
Loma Linda University Medical Center, Loma Linda, California
Children's Hospital Los Angeles, Los Angeles, California
Kaiser Permanente Los Angeles Medical Center, Los Angeles, California
Cedars Sinai Medical Center, Los Angeles, California
Mattel Children's Hospital UCLA, Los Angeles, California
Valley Children's Hospital, Madera, California
Kaiser Permanente-Oakland, Oakland, California
Children's Hospital of Orange County, Orange, California
Lucile Packard Children's Hospital Stanford University, Palo Alto, California
Sutter Medical Center Sacramento, Sacramento, California
University of California Davis Comprehensive Cancer Center, Sacramento, California
Kaiser Permanente-San Diego Zion, San Diego, California
Rady Children's Hospital - San Diego, San Diego, California
UCSF Medical Center-Mission Bay, San Francisco, California
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California
Children's Hospital Colorado, Aurora, Colorado
Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center, Denver, Colorado
Connecticut Children's Medical Center, Hartford, Connecticut
Yale University, New Haven, Connecticut
Alfred I duPont Hospital for Children, Wilmington, Delaware
Children's National Medical Center, Washington, District of Columbia
Golisano Children's Hospital of Southwest Florida, Fort Myers, Florida
University of Florida Health Science Center - Gainesville, Gainesville, Florida
Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood, Florida
Nemours Children's Clinic-Jacksonville, Jacksonville, Florida
AdventHealth Orlando, Orlando, Florida
Arnold Palmer Hospital for Children, Orlando, Florida
Nemours Children's Hospital, Orlando, Florida
Sacred Heart Hospital, Pensacola, Florida
Johns Hopkins All Children's Hospital, Saint Petersburg, Florida
Tampa General Hospital, Tampa, Florida
Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa, Florida
Saint Mary's Medical Center, West Palm Beach, Florida
Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta, Georgia
Memorial Health University Medical Center, Savannah, Georgia
Kapiolani Medical Center for Women and Children, Honolulu, Hawaii
Saint Luke's Cancer Institute - Boise, Boise, Idaho
Lurie Children's Hospital-Chicago, Chicago, Illinois
University of Illinois, Chicago, Illinois
University of Chicago Comprehensive Cancer Center, Chicago, Illinois
Loyola University Medical Center, Maywood, Illinois
Saint Jude Midwest Affiliate, Peoria, Illinois
Riley Hospital for Children, Indianapolis, Indiana
Blank Children's Hospital, Des Moines, Iowa
University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa
University of Kentucky/Markey Cancer Center, Lexington, Kentucky
Norton Children's Hospital, Louisville, Kentucky
Children's Hospital New Orleans, New Orleans, Louisiana
Ochsner Medical Center Jefferson, New Orleans, Louisiana
Maine Children's Cancer Program, Scarborough, Maine
Sinai Hospital of Baltimore, Baltimore, Maryland
Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland
Walter Reed National Military Medical Center, Bethesda, Maryland
Tufts Children's Hospital, Boston, Massachusetts
C S Mott Children's Hospital, Ann Arbor, Michigan
Bronson Battle Creek, Battle Creek, Michigan
Corewell Health Dearborn Hospital, Dearborn, Michigan
Children's Hospital of Michigan, Detroit, Michigan
Michigan State University Clinical Center, East Lansing, Michigan
Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids, Michigan
Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids, Michigan
Trinity Health Grand Rapids Hospital, Grand Rapids, Michigan
Bronson Methodist Hospital, Kalamazoo, Michigan
West Michigan Cancer Center, Kalamazoo, Michigan
Ascension Borgess Hospital, Kalamazoo, Michigan
Trinity Health Muskegon Hospital, Muskegon, Michigan
Corewell Health Lakeland Hospitals - Niles Hospital, Niles, Michigan
Cancer and Hematology Centers of Western Michigan - Norton Shores, Norton Shores, Michigan
Corewell Health Reed City Hospital, Reed City, Michigan
Corewell Health Children's, Royal Oak, Michigan
Corewell Health William Beaumont University Hospital, Royal Oak, Michigan
Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center, Saint Joseph, Michigan
Corewell Health Lakeland Hospitals - Saint Joseph Hospital, Saint Joseph, Michigan
Munson Medical Center, Traverse City, Michigan
Corewell Health Beaumont Troy Hospital, Troy, Michigan
University of Michigan Health - West, Wyoming, Michigan
Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis, Minnesota
University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota
University of Mississippi Medical Center, Jackson, Mississippi
Children's Mercy Hospitals and Clinics, Kansas City, Missouri
Cardinal Glennon Children's Medical Center, Saint Louis, Missouri
Washington University School of Medicine, Saint Louis, Missouri
Mercy Hospital Saint Louis, Saint Louis, Missouri
Children's Hospital and Medical Center of Omaha, Omaha, Nebraska
University of Nebraska Medical Center, Omaha, Nebraska
Carson Tahoe Regional Medical Center, Carson City, Nevada
Comprehensive Cancer Centers of Nevada - Henderson, Henderson, Nevada
Comprehensive Cancer Centers of Nevada-Horizon Ridge, Henderson, Nevada
Las Vegas Cancer Center-Henderson, Henderson, Nevada
OptumCare Cancer Care at Seven Hills, Henderson, Nevada
Comprehensive Cancer Centers of Nevada-Southeast Henderson, Henderson, Nevada
OptumCare Cancer Care at Charleston, Las Vegas, Nevada
Hope Cancer Care of Nevada, Las Vegas, Nevada
Sunrise Hospital and Medical Center, Las Vegas, Nevada
Ann M Wierman MD LTD, Las Vegas, Nevada
Comprehensive Cancer Centers of Nevada - Northwest, Las Vegas, Nevada
OptumCare Cancer Care at MountainView, Las Vegas, Nevada
Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas, Nevada
Comprehensive Cancer Centers of Nevada - Town Center, Las Vegas, Nevada
Comprehensive Cancer Centers of Nevada-Summerlin, Las Vegas, Nevada
Summerlin Hospital Medical Center, Las Vegas, Nevada
Las Vegas Cancer Center-Medical Center, Las Vegas, Nevada
Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada
OptumCare Cancer Care at Fort Apache, Las Vegas, Nevada
Comprehensive Cancer Centers of Nevada - Central Valley, Las Vegas, Nevada
Hope Cancer Care of Nevada-Pahrump, Pahrump, Nevada
Renown Regional Medical Center, Reno, Nevada
Saint Mary's Regional Medical Center, Reno, Nevada
Cancer Care Specialists - Reno, Reno, Nevada
Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon, New Hampshire
Hackensack University Medical Center, Hackensack, New Jersey
Morristown Medical Center, Morristown, New Jersey
Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick, New Jersey
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey
Newark Beth Israel Medical Center, Newark, New Jersey
Saint Joseph's Regional Medical Center, Paterson, New Jersey
Albany Medical Center, Albany, New York
Montefiore Medical Center - Moses Campus, Bronx, New York
Maimonides Medical Center, Brooklyn, New York
NYU Langone Hospital - Long Island, Mineola, New York
The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park, New York
Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York
Memorial Sloan Kettering Cancer Center, New York, New York
University of Rochester, Rochester, New York
Stony Brook University Medical Center, Stony Brook, New York
State University of New York Upstate Medical University, Syracuse, New York
UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina
Duke University Medical Center, Durham, North Carolina
East Carolina University, Greenville, North Carolina
Wake Forest University Health Sciences, Winston-Salem, North Carolina
Sanford Broadway Medical Center, Fargo, North Dakota
Children's Hospital Medical Center of Akron, Akron, Ohio
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
Rainbow Babies and Childrens Hospital, Cleveland, Ohio
Cleveland Clinic Foundation, Cleveland, Ohio
Nationwide Children's Hospital, Columbus, Ohio
Dayton Children's Hospital, Dayton, Ohio
ProMedica Flower Hospital, Sylvania, Ohio
ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, Toledo, Ohio
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
Legacy Emanuel Children's Hospital, Portland, Oregon
Oregon Health and Science University, Portland, Oregon
Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania
Geisinger Medical Center, Danville, Pennsylvania
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
Saint Christopher's Hospital for Children, Philadelphia, Pennsylvania
Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania
Rhode Island Hospital, Providence, Rhode Island
Prisma Health Richland Hospital, Columbia, South Carolina
BI-LO Charities Children's Cancer Center, Greenville, South Carolina
Prisma Health Cancer Institute - Eastside, Greenville, South Carolina
Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota
East Tennessee Childrens Hospital, Knoxville, Tennessee
The Children's Hospital at TriStar Centennial, Nashville, Tennessee
Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee
Dell Children's Medical Center of Central Texas, Austin, Texas
Driscoll Children's Hospital, Corpus Christi, Texas
Medical City Dallas Hospital, Dallas, Texas
UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas
El Paso Children's Hospital, El Paso, Texas
Cook Children's Medical Center, Fort Worth, Texas
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas
Children's Hospital of San Antonio, San Antonio, Texas
Methodist Children's Hospital of South Texas, San Antonio, Texas
University of Texas Health Science Center at San Antonio, San Antonio, Texas
Primary Children's Hospital, Salt Lake City, Utah
University of Vermont and State Agricultural College, Burlington, Vermont
Inova Fairfax Hospital, Falls Church, Virginia
Children's Hospital of The King's Daughters, Norfolk, Virginia
Overlake Medical Center, Bellevue, Washington
Valley Medical Center, Renton, Washington
Seattle Children's Hospital, Seattle, Washington
Providence Sacred Heart Medical Center and Children's Hospital, Spokane, Washington
Mary Bridge Children's Hospital and Health Center, Tacoma, Washington
Madigan Army Medical Center, Tacoma, Washington
North Star Lodge Cancer Center at Yakima Valley Memorial Hospital, Yakima, Washington
United Hospital Center, Bridgeport, West Virginia
WVUH-Berkely Medical Center, Martinsburg, West Virginia
West Virginia University Healthcare, Morgantown, West Virginia
Camden Clark Medical Center, Parkersburg, West Virginia
University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin
Children's Hospital of Wisconsin, Milwaukee, Wisconsin
John Hunter Children's Hospital, Hunter Regional Mail Centre, New South Wales
Sydney Children's Hospital, Randwick, New South Wales
The Children's Hospital at Westmead, Westmead, New South Wales
Queensland Children's Hospital, South Brisbane, Queensland
Perth Children's Hospital, Perth, Western Australia
CancerCare Manitoba, Winnipeg, Manitoba
IWK Health Centre, Halifax, Nova Scotia
The Montreal Children's Hospital of the MUHC, Montreal, Quebec
Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec
CHU de Quebec-Centre Hospitalier de l'Universite Laval (CHUL), Quebec, Not set
University Pediatric Hospital, San Juan, Not set
Conditions: Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Study of Belantamab Mafodotin Plus Standard of Care (SoC) in Newly Diagnosed Multiple Myeloma
Active Not Recruiting
This study will evaluate the safety, pharmacokinetics, pharmacodynamics and clinical activity of belantamab mafodotin in combination with Velcade (bortezomib), Revlimid (lenalidomide), dexamethasone (VRd) and will determine recommended phase 3 dose (RP3D) in adult participants with newly diagnosed multiple myeloma (NDMM). Participants will receive the combination of bortezomib, lenalidomide and dexamethasone (VRd) on a 3-week cycle until cycle 8, followed by the combination of lenalidomide and d... Read More
This study will evaluate the safety, pharmacokinetics, pharmacodynamics and clinical activity of belantamab mafodotin in combination with Velcade (bortezomib), Revlimid (lenalidomide), dexamethasone (VRd) and will determine recommended phase 3 dose (RP3D) in adult participants with newly diagnosed multiple myeloma (NDMM). Participants will receive the combination of bortezomib, lenalidomide and dexamethasone (VRd) on a 3-week cycle until cycle 8, followed by the combination of lenalidomide and dexamethasone (Rd) on a 4-week cycle thereafter as per dosing schedule. Participants will receive belantamab mafodotin on a schedule that is dependent on the cohort to which they are assigned. Belantamab mafodotin will be administered in combination with VRd every 3 weeks (Q3W), every 6 weeks (Q6W), or every 9 weeks (Q9W) to Cycle 8, and then in combination with Rd every 4 weeks (Q4W), every 8 weeks (Q8W), or every 12 weeks (Q12W) thereafter. Participants will complete an End of Treatment (EOT) visit at the point of study treatment discontinuation, followed by a Safety Follow-up visit 70 days after EOT. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/24/2025
Locations: GSK Investigational Site, Westwood, Kansas +29 locations
GSK Investigational Site, Westwood, Kansas
GSK Investigational Site, Charlotte, North Carolina
GSK Investigational Site, Madison, Wisconsin
GSK Investigational Site, Newcastle, New South Wales
GSK Investigational Site, Clayton, Victoria
GSK Investigational Site, Fitzroy, Victoria
GSK Investigational Site, Edmonton, Alberta
GSK Investigational Site, London, Ontario
GSK Investigational Site, Poitiers, Not set
GSK Investigational Site, Dresden, Not set
GSK Investigational Site, Hamburg, Not set
GSK Investigational Site, Schwerin, Not set
GSK Investigational Site, Tuebingen, Not set
GSK Investigational Site, Bologna, Not set
GSK Investigational Site, Meldola FC, Not set
GSK Investigational Site, Seoul, Not set
GSK Investigational Site, Seoul, Not set
GSK Investigational Site, Seoul, Not set
GSK Investigational Site, Lublin, Not set
GSK Investigational Site, Poznan, Not set
GSK Investigational Site, Badalona, Not set
GSK Investigational Site, Barcelona, Not set
GSK Investigational Site, Madrid, Not set
GSK Investigational Site, Malaga, Not set
GSK Investigational Site, PamplonaNavarra, Not set
GSK Investigational Site, Pozuelo De AlarcOn Madr, Not set
GSK Investigational Site, Santander, Not set
GSK Investigational Site, Leicester, Not set
GSK Investigational Site, Oxford, Not set
GSK Investigational Site, Southampton, Not set
Conditions: Multiple Myeloma
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Suspended
This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in treating patients with newly diagnosed B acute lymphoblastic leukemia. Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or... Read More
This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in treating patients with newly diagnosed B acute lymphoblastic leukemia. Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving inotuzumab ozogamicin with chemotherapy may work better in treating young adults with B acute lymphoblastic leukemia. Read Less
Gender:
ALL
Ages:
Between 18 years and 39 years
Trial Updated:
06/24/2025
Locations: University of Alabama at Birmingham Cancer Center, Birmingham, Alabama +457 locations
University of Alabama at Birmingham Cancer Center, Birmingham, Alabama
Anchorage Associates in Radiation Medicine, Anchorage, Alaska
Anchorage Radiation Therapy Center, Anchorage, Alaska
Alaska Breast Care and Surgery LLC, Anchorage, Alaska
Alaska Oncology and Hematology LLC, Anchorage, Alaska
Alaska Women's Cancer Care, Anchorage, Alaska
Anchorage Oncology Centre, Anchorage, Alaska
Katmai Oncology Group, Anchorage, Alaska
Providence Alaska Medical Center, Anchorage, Alaska
Fairbanks Memorial Hospital, Fairbanks, Alaska
Kingman Regional Medical Center, Kingman, Arizona
Mayo Clinic Hospital in Arizona, Phoenix, Arizona
Mercy Hospital Fort Smith, Fort Smith, Arkansas
Kaiser Permanente-Deer Valley Medical Center, Antioch, California
PCR Oncology, Arroyo Grande, California
Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank, California
Community Cancer Institute, Clovis, California
University Oncology Associates, Clovis, California
UC Irvine Health Cancer Center-Newport, Costa Mesa, California
Kaiser Permanente Dublin, Dublin, California
Kaiser Permanente-Fremont, Fremont, California
Fresno Cancer Center, Fresno, California
Kaiser Permanente-Fresno, Fresno, California
Kaiser Permanente-Modesto, Modesto, California
Kaiser Permanente Oakland-Broadway, Oakland, California
Kaiser Permanente-Oakland, Oakland, California
UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California
Stanford Cancer Institute Palo Alto, Palo Alto, California
Kaiser Permanente-Rancho Cordova Cancer Center, Rancho Cordova, California
Kaiser Permanente- Marshall Medical Offices, Redwood City, California
Kaiser Permanente-Redwood City, Redwood City, California
Kaiser Permanente-Richmond, Richmond, California
Rohnert Park Cancer Center, Rohnert Park, California
Kaiser Permanente-Roseville, Roseville, California
The Permanente Medical Group-Roseville Radiation Oncology, Roseville, California
Kaiser Permanente Downtown Commons, Sacramento, California
University of California Davis Comprehensive Cancer Center, Sacramento, California
Kaiser Permanente-South Sacramento, Sacramento, California
South Sacramento Cancer Center, Sacramento, California
Kaiser Permanente Sacramento Medical Center, Sacramento, California
Kaiser Permanente-San Francisco, San Francisco, California
Kaiser Permanente-Santa Teresa-San Jose, San Jose, California
Kaiser Permanente San Leandro, San Leandro, California
Kaiser Permanente-San Rafael, San Rafael, California
Kaiser San Rafael-Gallinas, San Rafael, California
Kaiser Permanente Medical Center - Santa Clara, Santa Clara, California
Kaiser Permanente-Santa Rosa, Santa Rosa, California
Kaiser Permanente Cancer Treatment Center, South San Francisco, California
Kaiser Permanente-South San Francisco, South San Francisco, California
Kaiser Permanente-Stockton, Stockton, California
Kaiser Permanente Medical Center-Vacaville, Vacaville, California
Kaiser Permanente-Vallejo, Vallejo, California
Kaiser Permanente-Walnut Creek, Walnut Creek, California
Rocky Mountain Cancer Centers-Aurora, Aurora, Colorado
The Medical Center of Aurora, Aurora, Colorado
Boulder Community Hospital, Boulder, Colorado
Boulder Community Foothills Hospital, Boulder, Colorado
Rocky Mountain Cancer Centers-Boulder, Boulder, Colorado
Rocky Mountain Cancer Centers - Centennial, Centennial, Colorado
Cancer Center of Colorado at Sloan's Lake, Denver, Colorado
National Jewish Health-Main Campus, Denver, Colorado
The Women's Imaging Center, Denver, Colorado
Colorado Blood Cancer Institute, Denver, Colorado
Presbyterian - Saint Lukes Medical Center - Health One, Denver, Colorado
Rocky Mountain Cancer Centers-Midtown, Denver, Colorado
Saint Joseph Hospital - Cancer Centers of Colorado, Denver, Colorado
Rocky Mountain Cancer Centers-Rose, Denver, Colorado
Rose Medical Center, Denver, Colorado
Western Surgical Care, Denver, Colorado
Mountain Blue Cancer Care Center - Swedish, Englewood, Colorado
Rocky Mountain Cancer Centers - Swedish, Englewood, Colorado
Swedish Medical Center, Englewood, Colorado
The Melanoma and Skin Cancer Institute, Englewood, Colorado
National Jewish Health-Western Hematology Oncology, Golden, Colorado
Saint Mary's Hospital and Regional Medical Center, Grand Junction, Colorado
Banner North Colorado Medical Center, Greeley, Colorado
Good Samaritan Hospital - Cancer Centers of Colorado, Lafayette, Colorado
Rocky Mountain Cancer Centers-Lakewood, Lakewood, Colorado
Rocky Mountain Cancer Centers-Littleton, Littleton, Colorado
Rocky Mountain Cancer Centers-Sky Ridge, Lone Tree, Colorado
Sky Ridge Medical Center, Lone Tree, Colorado
Banner McKee Medical Center, Loveland, Colorado
National Jewish Health-Northern Hematology Oncology, Thornton, Colorado
Rocky Mountain Cancer Centers-Thornton, Thornton, Colorado
Intermountain Health Lutheran Hospital, Wheat Ridge, Colorado
Smilow Cancer Hospital Care Center at Saint Francis, Hartford, Connecticut
Smilow Cancer Center/Yale-New Haven Hospital, New Haven, Connecticut
Yale University, New Haven, Connecticut
Holy Cross Hospital, Fort Lauderdale, Florida
Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood, Florida
Miami Cancer Institute, Miami, Florida
Orlando Health Cancer Institute, Orlando, Florida
Memorial Hospital West, Pembroke Pines, Florida
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia
Augusta University Medical Center, Augusta, Georgia
Hawaii Cancer Care - Westridge, 'Aiea, Hawaii
Pali Momi Medical Center, 'Aiea, Hawaii
Queen's Cancer Center - Pearlridge, 'Aiea, Hawaii
The Cancer Center of Hawaii-Pali Momi, 'Aiea, Hawaii
Island Urology-Hilo, Hilo, Hawaii
Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu, Hawaii
Island Urology, Honolulu, Hawaii
Queen's Cancer Cenrer - POB I, Honolulu, Hawaii
Queen's Medical Center, Honolulu, Hawaii
Straub Clinic and Hospital, Honolulu, Hawaii
University of Hawaii Cancer Center, Honolulu, Hawaii
Hawaii Cancer Care Inc-Liliha, Honolulu, Hawaii
Kuakini Medical Center, Honolulu, Hawaii
Queen's Cancer Center - Kuakini, Honolulu, Hawaii
The Cancer Center of Hawaii-Liliha, Honolulu, Hawaii
Kaiser Permanente Moanalua Medical Center, Honolulu, Hawaii
Kapiolani Medical Center for Women and Children, Honolulu, Hawaii
Wilcox Memorial Hospital and Kauai Medical Clinic, Lihue, Hawaii
Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho
Saint Luke's Cancer Institute - Boise, Boise, Idaho
Saint Alphonsus Cancer Care Center-Caldwell, Caldwell, Idaho
Kootenai Health - Coeur d'Alene, Coeur d'Alene, Idaho
Walter Knox Memorial Hospital, Emmett, Idaho
Saint Luke's Cancer Institute - Fruitland, Fruitland, Idaho
Idaho Urologic Institute-Meridian, Meridian, Idaho
Saint Luke's Cancer Institute - Meridian, Meridian, Idaho
Saint Alphonsus Cancer Care Center-Nampa, Nampa, Idaho
Saint Luke's Cancer Institute - Nampa, Nampa, Idaho
Kootenai Clinic Cancer Services - Post Falls, Post Falls, Idaho
Kootenai Clinic Cancer Services - Sandpoint, Sandpoint, Idaho
Saint Luke's Cancer Institute - Twin Falls, Twin Falls, Idaho
OSF Saint Anthony's Health Center, Alton, Illinois
Loyola Center for Health at Burr Ridge, Burr Ridge, Illinois
Northwestern University, Chicago, Illinois
Rush University Medical Center, Chicago, Illinois
University of Illinois, Chicago, Illinois
University of Chicago Comprehensive Cancer Center, Chicago, Illinois
NorthShore University HealthSystem-Evanston Hospital, Evanston, Illinois
NorthShore University HealthSystem-Glenbrook Hospital, Glenview, Illinois
NorthShore University HealthSystem-Highland Park Hospital, Highland Park, Illinois
Loyola Medicine Homer Glen, Homer Glen, Illinois
Northwestern Medicine Lake Forest Hospital, Lake Forest, Illinois
Rush Cancer Care in Lisle, Lisle, Illinois
Loyola University Medical Center, Maywood, Illinois
Marjorie Weinberg Cancer Center at Loyola-Gottlieb, Melrose Park, Illinois
SSM Health Good Samaritan, Mount Vernon, Illinois
UC Comprehensive Cancer Center at Silver Cross, New Lenox, Illinois
University of Chicago Medicine-Orland Park, Orland Park, Illinois
Saint Anthony Regional Hospital, Carroll, Iowa
Blank Children's Hospital, Des Moines, Iowa
Iowa Methodist Medical Center, Des Moines, Iowa
UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines, Iowa
Broadlawns Medical Center, Des Moines, Iowa
Iowa Lutheran Hospital, Des Moines, Iowa
Trinity Regional Medical Center, Fort Dodge, Iowa
University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa
Methodist West Hospital, West Des Moines, Iowa
Central Care Cancer Center - Garden City, Garden City, Kansas
Central Care Cancer Center - Great Bend, Great Bend, Kansas
University of Kansas Cancer Center, Kansas City, Kansas
Lawrence Memorial Hospital, Lawrence, Kansas
University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas
Cancer Center of Kansas-Wichita Medical Arts Tower, Wichita, Kansas
Ascension Via Christi Hospitals Wichita, Wichita, Kansas
Cancer Center of Kansas - Wichita, Wichita, Kansas
Wesley Medical Center, Wichita, Kansas
University of Kentucky/Markey Cancer Center, Lexington, Kentucky
Ochsner Health Center-Summa, Baton Rouge, Louisiana
Medical Center of Baton Rouge, Baton Rouge, Louisiana
Ochsner High Grove, Baton Rouge, Louisiana
Ochsner Medical Center Jefferson, New Orleans, Louisiana
University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland
Massachusetts General Hospital Cancer Center, Boston, Massachusetts
Beth Israel Deaconess Medical Center, Boston, Massachusetts
Dana-Farber Cancer Institute, Boston, Massachusetts
Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor, Michigan
Bronson Battle Creek, Battle Creek, Michigan
Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton, Michigan
Trinity Health Medical Center - Brighton, Brighton, Michigan
Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton, Michigan
Trinity Health Medical Center - Canton, Canton, Michigan
Caro Cancer Center, Caro, Michigan
Chelsea Hospital, Chelsea, Michigan
Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea, Michigan
Hematology Oncology Consultants-Clarkston, Clarkston, Michigan
Newland Medical Associates-Clarkston, Clarkston, Michigan
Wayne State University/Karmanos Cancer Institute, Detroit, Michigan
Henry Ford Health Saint John Hospital, Detroit, Michigan
Henry Ford River District Hospital, East China Township, Michigan
Weisberg Cancer Treatment Center, Farmington Hills, Michigan
Cancer Hematology Centers - Flint, Flint, Michigan
Genesee Hematology Oncology PC, Flint, Michigan
Genesys Hurley Cancer Institute, Flint, Michigan
Hurley Medical Center, Flint, Michigan
Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids, Michigan
Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids, Michigan
Trinity Health Grand Rapids Hospital, Grand Rapids, Michigan
Henry Ford Saint John Hospital - Academic, Grosse Pointe Woods, Michigan
Henry Ford Saint John Hospital - Breast, Grosse Pointe Woods, Michigan
Henry Ford Saint John Hospital - Van Elslander, Grosse Pointe Woods, Michigan
Bronson Methodist Hospital, Kalamazoo, Michigan
West Michigan Cancer Center, Kalamazoo, Michigan
Ascension Borgess Cancer Center, Kalamazoo, Michigan
Ascension Borgess Hospital, Kalamazoo, Michigan
University of Michigan Health - Sparrow Lansing, Lansing, Michigan
Hope Cancer Clinic, Livonia, Michigan
Trinity Health Saint Mary Mercy Livonia Hospital, Livonia, Michigan
Henry Ford Saint John Hospital - Macomb Medical, Macomb, Michigan
Henry Ford Warren Hospital - Breast Macomb, Macomb, Michigan
Saint Mary's Oncology/Hematology Associates of Marlette, Marlette, Michigan
Trinity Health Muskegon Hospital, Muskegon, Michigan
Corewell Health Lakeland Hospitals - Niles Hospital, Niles, Michigan
Cancer and Hematology Centers of Western Michigan - Norton Shores, Norton Shores, Michigan
Hope Cancer Center, Pontiac, Michigan
Michigan Healthcare Professionals Pontiac, Pontiac, Michigan
Newland Medical Associates-Pontiac, Pontiac, Michigan
Trinity Health Saint Joseph Mercy Oakland Hospital, Pontiac, Michigan
Corewell Health Reed City Hospital, Reed City, Michigan
Henry Ford Rochester Hospital, Rochester Hills, Michigan
MyMichigan Medical Center Saginaw, Saginaw, Michigan
Oncology Hematology Associates of Saginaw Valley PC, Saginaw, Michigan
Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center, Saint Joseph, Michigan
Corewell Health Lakeland Hospitals - Saint Joseph Hospital, Saint Joseph, Michigan
Bhadresh Nayak MD PC-Sterling Heights, Sterling Heights, Michigan
MyMichigan Medical Center Tawas, Tawas City, Michigan
Munson Medical Center, Traverse City, Michigan
Advanced Breast Care Center PLLC, Warren, Michigan
Henry Ford Health Warren Hospital, Warren, Michigan
Henry Ford Madison Heights Hospital - Breast, Warren, Michigan
Henry Ford Warren Hospital - GLCMS, Warren, Michigan
Macomb Hematology Oncology PC, Warren, Michigan
Saint Mary's Oncology/Hematology Associates of West Branch, West Branch, Michigan
University of Michigan Health - West, Wyoming, Michigan
Huron Gastroenterology PC, Ypsilanti, Michigan
Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti, Michigan
Riverwood Healthcare Center, Aitkin, Minnesota
Essentia Health Saint Joseph's Medical Center, Brainerd, Minnesota
Fairview Ridges Hospital, Burnsville, Minnesota
Minnesota Oncology - Burnsville, Burnsville, Minnesota
Cambridge Medical Center, Cambridge, Minnesota
Mercy Hospital, Coon Rapids, Minnesota
Essentia Health - Deer River Clinic, Deer River, Minnesota
Essentia Health Saint Mary's - Detroit Lakes Clinic, Detroit Lakes, Minnesota
Essentia Health Cancer Center, Duluth, Minnesota
Essentia Health Saint Mary's Medical Center, Duluth, Minnesota
Miller-Dwan Hospital, Duluth, Minnesota
Fairview Southdale Hospital, Edina, Minnesota
Lake Region Healthcare Corporation-Cancer Care, Fergus Falls, Minnesota
Essentia Health - Fosston, Fosston, Minnesota
Unity Hospital, Fridley, Minnesota
Essentia Health Hibbing Clinic, Hibbing, Minnesota
Fairview Clinics and Surgery Center Maple Grove, Maple Grove, Minnesota
Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota
Saint John's Hospital - Healtheast, Maplewood, Minnesota
Abbott-Northwestern Hospital, Minneapolis, Minnesota
Hennepin County Medical Center, Minneapolis, Minnesota
Health Partners Inc, Minneapolis, Minnesota
Monticello Cancer Center, Monticello, Minnesota
New Ulm Medical Center, New Ulm, Minnesota
Essentia Health - Park Rapids, Park Rapids, Minnesota
Fairview Northland Medical Center, Princeton, Minnesota
North Memorial Medical Health Center, Robbinsdale, Minnesota
Mayo Clinic in Rochester, Rochester, Minnesota
Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota
Regions Hospital, Saint Paul, Minnesota
United Hospital, Saint Paul, Minnesota
Essentia Health Sandstone, Sandstone, Minnesota
Saint Francis Regional Medical Center, Shakopee, Minnesota
Lakeview Hospital, Stillwater, Minnesota
Essentia Health Virginia Clinic, Virginia, Minnesota
Ridgeview Medical Center, Waconia, Minnesota
Rice Memorial Hospital, Willmar, Minnesota
Minnesota Oncology Hematology PA-Woodbury, Woodbury, Minnesota
Fairview Lakes Medical Center, Wyoming, Minnesota
Saint Louis Cancer and Breast Institute-Ballwin, Ballwin, Missouri
Central Care Cancer Center - Bolivar, Bolivar, Missouri
Cox Cancer Center Branson, Branson, Missouri
Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri
Freeman Health System, Joplin, Missouri
Mercy Hospital Joplin, Joplin, Missouri
Mercy Clinic-Rolla-Cancer and Hematology, Rolla, Missouri
Phelps Health Delbert Day Cancer Institute, Rolla, Missouri
Heartland Regional Medical Center, Saint Joseph, Missouri
Saint Louis Cancer and Breast Institute-South City, Saint Louis, Missouri
Washington University School of Medicine, Saint Louis, Missouri
Mercy Hospital South, Saint Louis, Missouri
Siteman Cancer Center-South County, Saint Louis, Missouri
Mercy Hospital Saint Louis, Saint Louis, Missouri
Siteman Cancer Center at Saint Peters Hospital, Saint Peters, Missouri
Mercy Hospital Springfield, Springfield, Missouri
CoxHealth South Hospital, Springfield, Missouri
Mercy Hospital Washington, Washington, Missouri
Community Hospital of Anaconda, Anaconda, Montana
Billings Clinic Cancer Center, Billings, Montana
Saint Vincent Healthcare, Billings, Montana
Saint Vincent Frontier Cancer Center, Billings, Montana
Bozeman Health Deaconess Hospital, Bozeman, Montana
Saint James Community Hospital and Cancer Treatment Center, Butte, Montana
Benefis Sletten Cancer Institute, Great Falls, Montana
Great Falls Clinic, Great Falls, Montana
Logan Health Medical Center, Kalispell, Montana
Saint Patrick Hospital - Community Hospital, Missoula, Montana
Community Medical Center, Missoula, Montana
Nebraska Medicine-Village Pointe, Omaha, Nebraska
University of Nebraska Medical Center, Omaha, Nebraska
Carson Tahoe Regional Medical Center, Carson City, Nevada
Cancer and Blood Specialists-Henderson, Henderson, Nevada
Comprehensive Cancer Centers of Nevada - Henderson, Henderson, Nevada
Comprehensive Cancer Centers of Nevada-Horizon Ridge, Henderson, Nevada
Las Vegas Cancer Center-Henderson, Henderson, Nevada
OptumCare Cancer Care at Seven Hills, Henderson, Nevada
Comprehensive Cancer Centers of Nevada-Southeast Henderson, Henderson, Nevada
GenesisCare USA - Henderson, Henderson, Nevada
Las Vegas Urology - Green Valley, Henderson, Nevada
Las Vegas Urology - Pebble, Henderson, Nevada
Urology Specialists of Nevada - Green Valley, Henderson, Nevada
Las Vegas Urology - Pecos, Las Vegas, Nevada
Desert West Surgery, Las Vegas, Nevada
OptumCare Cancer Care at Charleston, Las Vegas, Nevada
University Medical Center of Southern Nevada, Las Vegas, Nevada
Hope Cancer Care of Nevada, Las Vegas, Nevada
Radiation Oncology Centers of Nevada Central, Las Vegas, Nevada
Urology Specialists of Nevada - Central, Las Vegas, Nevada
GenesisCare USA - Las Vegas, Las Vegas, Nevada
Sunrise Hospital and Medical Center, Las Vegas, Nevada
Las Vegas Prostate Cancer Center, Las Vegas, Nevada
Las Vegas Urology - Sunset, Las Vegas, Nevada
Urology Specialists of Nevada - Southwest, Las Vegas, Nevada
Radiation Oncology Centers of Nevada Southeast, Las Vegas, Nevada
Ann M Wierman MD LTD, Las Vegas, Nevada
Comprehensive Cancer Centers of Nevada - Northwest, Las Vegas, Nevada
GenesisCare USA - Vegas Tenaya, Las Vegas, Nevada
Las Vegas Urology - Cathedral Rock, Las Vegas, Nevada
Las Vegas Urology - Smoke Ranch, Las Vegas, Nevada
OptumCare Cancer Care at MountainView, Las Vegas, Nevada
Urology Specialists of Nevada - Northwest, Las Vegas, Nevada
Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas, Nevada
Comprehensive Cancer Centers of Nevada - Town Center, Las Vegas, Nevada
Comprehensive Cancer Centers of Nevada-Summerlin, Las Vegas, Nevada
Summerlin Hospital Medical Center, Las Vegas, Nevada
Las Vegas Cancer Center-Medical Center, Las Vegas, Nevada
Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada
GenesisCare USA - Fort Apache, Las Vegas, Nevada
OptumCare Cancer Care at Fort Apache, Las Vegas, Nevada
Comprehensive Cancer Centers of Nevada - Central Valley, Las Vegas, Nevada
University Cancer Center, Las Vegas, Nevada
Hope Cancer Care of Nevada-Pahrump, Pahrump, Nevada
Renown Regional Medical Center, Reno, Nevada
Saint Mary's Regional Medical Center, Reno, Nevada
Radiation Oncology Associates, Reno, Nevada
University of New Mexico Cancer Center, Albuquerque, New Mexico
Roswell Park Cancer Institute, Buffalo, New York
Northwell Health/Center for Advanced Medicine, Lake Success, New York
North Shore University Hospital, Manhasset, New York
Long Island Jewish Medical Center, New Hyde Park, New York
Mount Sinai Hospital, New York, New York
NYP/Weill Cornell Medical Center, New York, New York
University of Rochester, Rochester, New York
Stony Brook University Medical Center, Stony Brook, New York
State University of New York Upstate Medical University, Syracuse, New York
Upstate Cancer Center at Verona, Verona, New York
UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
Duke University Medical Center, Durham, North Carolina
East Carolina University, Greenville, North Carolina
Wake Forest University Health Sciences, Winston-Salem, North Carolina
Essentia Health Cancer Center-South University Clinic, Fargo, North Dakota
Essentia Health - Jamestown Clinic, Jamestown, North Dakota
University of Cincinnati Cancer Center-UC Medical Center, Cincinnati, Ohio
Case Western Reserve University, Cleveland, Ohio
Cleveland Clinic Foundation, Cleveland, Ohio
Ohio State University Comprehensive Cancer Center, Columbus, Ohio
University of Cincinnati Cancer Center-West Chester, West Chester, Ohio
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
Mercy Hospital Oklahoma City, Oklahoma City, Oklahoma
Saint Alphonsus Cancer Care Center-Baker City, Baker City, Oregon
Saint Charles Health System, Bend, Oregon
Clackamas Radiation Oncology Center, Clackamas, Oregon
Providence Cancer Institute Clackamas Clinic, Clackamas, Oregon
Bay Area Hospital, Coos Bay, Oregon
Providence Newberg Medical Center, Newberg, Oregon
Saint Alphonsus Cancer Care Center-Ontario, Ontario, Oregon
Providence Portland Medical Center, Portland, Oregon
Providence Saint Vincent Medical Center, Portland, Oregon
Oregon Health and Science University, Portland, Oregon
Saint Charles Health System-Redmond, Redmond, Oregon
Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania
Lehigh Valley Hospital - Muhlenberg, Bethlehem, Pennsylvania
Pocono Medical Center, East Stroudsburg, Pennsylvania
Lehigh Valley Hospital-Hazleton, Hazleton, Pennsylvania
University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
Rhode Island Hospital, Providence, Rhode Island
Miriam Hospital, Providence, Rhode Island
Prisma Health Cancer Institute - Spartanburg, Boiling Springs, South Carolina
Prisma Health Cancer Institute - Laurens, Clinton, South Carolina
Prisma Health Richland Hospital, Columbia, South Carolina
Prisma Health Cancer Institute - Easley, Easley, South Carolina
Saint Francis Hospital, Greenville, South Carolina
BI-LO Charities Children's Cancer Center, Greenville, South Carolina
Prisma Health Cancer Institute - Butternut, Greenville, South Carolina
Prisma Health Cancer Institute - Faris, Greenville, South Carolina
Prisma Health Greenville Memorial Hospital, Greenville, South Carolina
Saint Francis Cancer Center, Greenville, South Carolina
Prisma Health Cancer Institute - Eastside, Greenville, South Carolina
Prisma Health Cancer Institute - Greer, Greer, South Carolina
Prisma Health Cancer Institute - Seneca, Seneca, South Carolina
Houston Methodist Hospital, Houston, Texas
Covenant Medical Center-Lakeside, Lubbock, Texas
American Fork Hospital / Huntsman Intermountain Cancer Center, American Fork, Utah
Sandra L Maxwell Cancer Center, Cedar City, Utah
Logan Regional Hospital, Logan, Utah
Intermountain Medical Center, Murray, Utah
McKay-Dee Hospital Center, Ogden, Utah
Utah Valley Regional Medical Center, Provo, Utah
Riverton Hospital, Riverton, Utah
Saint George Regional Medical Center, Saint George, Utah
Utah Cancer Specialists-Salt Lake City, Salt Lake City, Utah
Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah
LDS Hospital, Salt Lake City, Utah
Inova Schar Cancer Institute, Fairfax, Virginia
Inova Fairfax Hospital, Falls Church, Virginia
Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia
Providence Regional Cancer System-Aberdeen, Aberdeen, Washington
Overlake Medical Center, Bellevue, Washington
PeaceHealth Saint Joseph Medical Center, Bellingham, Washington
Providence Regional Cancer System-Centralia, Centralia, Washington
Swedish Cancer Institute-Edmonds, Edmonds, Washington
Providence Regional Cancer Partnership, Everett, Washington
Swedish Cancer Institute-Issaquah, Issaquah, Washington
Kadlec Clinic Hematology and Oncology, Kennewick, Washington
Providence Regional Cancer System-Lacey, Lacey, Washington
PeaceHealth Saint John Medical Center, Longview, Washington
Jefferson Healthcare, Port Townsend, Washington
Valley Medical Center, Renton, Washington
Pacific Gynecology Specialists, Seattle, Washington
Swedish Medical Center-Ballard Campus, Seattle, Washington
Kaiser Permanente Washington, Seattle, Washington
Swedish Medical Center-Cherry Hill, Seattle, Washington
Swedish Medical Center-First Hill, Seattle, Washington
PeaceHealth United General Medical Center, Sedro-Woolley, Washington
Providence Regional Cancer System-Shelton, Shelton, Washington
PeaceHealth Southwest Medical Center, Vancouver, Washington
Providence Saint Mary Regional Cancer Center, Walla Walla, Washington
North Star Lodge Cancer Center at Yakima Valley Memorial Hospital, Yakima, Washington
Providence Regional Cancer System-Yelm, Yelm, Washington
Duluth Clinic Ashland, Ashland, Wisconsin
Northwest Wisconsin Cancer Center, Ashland, Wisconsin
Essentia Health-Hayward Clinic, Hayward, Wisconsin
University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin
Marshfield Medical Center-Marshfield, Marshfield, Wisconsin
Medical College of Wisconsin, Milwaukee, Wisconsin
Cancer Center of Western Wisconsin, New Richmond, Wisconsin
Essentia Health-Spooner Clinic, Spooner, Wisconsin
Essentia Health Saint Mary's Hospital - Superior, Superior, Wisconsin
Cheyenne Regional Medical Center-West, Cheyenne, Wyoming
Billings Clinic-Cody, Cody, Wyoming
Welch Cancer Center, Sheridan, Wyoming
Arthur J E Child Comprehensive Cancer Centre, Calgary, Alberta
CancerCare Manitoba, Winnipeg, Manitoba
QEII Health Sciences Centre/Nova Scotia Health Authority, Halifax, Nova Scotia
Ottawa Hospital and Cancer Center-General Campus, Ottawa, Ontario
Jewish General Hospital, Montreal, Quebec
Conditions: B Acute Lymphoblastic Leukemia
Study of Intravenous Amisulpride for Prophylaxis of Post-operative Nausea and Vomiting (PONV) in Pediatric Patients
Completed
Randomized, double-blind, pediatric trial of amisulpride for prophylaxis of post operative nausea and vomiting
Randomized, double-blind, pediatric trial of amisulpride for prophylaxis of post operative nausea and vomiting Read Less
Gender:
ALL
Ages:
Between 2 months and 17 years
Trial Updated:
06/20/2025
Locations: Helen Keller Hospital, Sheffield, Alabama +13 locations
Helen Keller Hospital, Sheffield, Alabama
Emory Healthcare - Emory University Hospital, Atlanta, Georgia
University of Minnesota Masonic Children's Hospital, Minneapolis, Minnesota
The Children's Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania
UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania
The Hospital for Sick Children, Toronto, Ontario
McGill University Health Centre - The Montréal Children's Hospital, Montréal, Quebec
HCL - Hôpital Mère Enfant, Bron, Not set
CHU Strasbourg - Hopital Hautepierre, Strasbourg, Not set
Universitätsklinikum Würzburg, Würzburg, Bayern
Ambulantes Operieren Marburg, Marburg, Hessen
Universitaetsklinikum Giessen und Marburg GmbH, Marburg, Hessen
Universitaetsklinikum Bonn - Klinik für Anaesthesiologie & Operative Intensivmedizin, Bonn, Nordrhein-Westfalen
Helios Klinikum Aue, Aue, Not set
Conditions: Nausea and Vomiting, Postoperative
37 - 48 of 294